Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ischemic Heart Disease

  Free Subscription


Articles published in J Am Coll Cardiol

Retrieve available abstracts of 525 articles:
HTML format
Text format



Single Articles


    May 2017
  1. OUELLETTE ML, Beller GA, Loffler AI, Workman VK, et al
    Appropriate Referrals of Angiography Despite High Prevalence of Normal Coronary Arteries or Nonobstructive CAD.
    J Am Coll Cardiol. 2017;69:2673-2675.
    PubMed     Text format    


  2. KRITTANAWONG C, Zhang H, Wang Z, Aydar M, et al
    Artificial Intelligence in Precision Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;69:2657-2664.
    PubMed     Text format     Abstract available


  3. SATTAR N, Petrie MC, Zinman B, Januzzi JL Jr, et al
    Novel Diabetes Drugs and the Cardiovascular Specialist.
    J Am Coll Cardiol. 2017;69:2646-2656.
    PubMed     Text format     Abstract available


  4. ELZE MC, Gregson J, Baber U, Williamson E, et al
    Reply: Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?
    J Am Coll Cardiol. 2017;69:2576-2577.
    PubMed     Text format    


  5. BIONDI-ZOCCAI G, Marullo AGM, Peruzzi M, Palmerini T, et al
    Last Nail in the Coffin for Propensity Scores in Observational Cardiovascular Studies?
    J Am Coll Cardiol. 2017;69:2575-2576.
    PubMed     Text format    


  6. BOKMA JP, Winter MM, Kuijpers JM, Jongbloed MR, et al
    Role of Acquired Cardiovascular Disease in Tetralogy of Fallot Patients >50 Years of Age.
    J Am Coll Cardiol. 2017;69:2465-2466.
    PubMed     Text format    


  7. ALBAGHDADI M
    Global Cardiovascular Health: A Role for the Interventionalist.
    J Am Coll Cardiol. 2017;69:2461-2464.
    PubMed     Text format    


  8. MUNZEL T, Heusch G
    Chest Pain Unit Network in Germany: Its Effect on Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2017;69:2459-2460.
    PubMed     Text format    


  9. MUNTNER P, Whelton PK
    Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.
    J Am Coll Cardiol. 2017;69:2446-2456.
    PubMed     Text format     Abstract available


  10. ROTH GA, Johnson C, Abajobir A, Abd-Allah F, et al
    Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.
    J Am Coll Cardiol. 2017 May 15. pii: S0735-1097(17)37244.
    PubMed     Text format     Abstract available


  11. ANDO G, Cortese B, Russo F, Rothenbuhler M, et al
    Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX.
    J Am Coll Cardiol. 2017 May 11. pii: S0735-1097(17)36897.
    PubMed     Text format     Abstract available


  12. MOZAFFARIAN D
    Scourge of Global Cardiovascular Disease: Time for Health Care Systems Reform and Precision Population Health.
    J Am Coll Cardiol. 2017 May 10. pii: S0735-1097(17)37316.
    PubMed     Text format    


  13. ELIAS J, Hoebers LP, van Dongen IM, Claessen BEPM, et al
    Impact of Chronic Total Occlusion Location on LV Function in ST-Segment Elevation Myocardial Infarction Patients.
    J Am Coll Cardiol. 2017;69:2347-2348.
    PubMed     Text format    


  14. STONE PH
    Ranolazine in Diabetics With Stable Ischemic Heart Disease: Greatest Efficacy Related to Greatest Metabolic Stress.
    J Am Coll Cardiol. 2017;69:2314-2316.
    PubMed     Text format    


  15. NIEDERSEER D, Stadlmayr A, Huber-Schonauer U, Ploderl M, et al
    Cardiovascular Risk and Known Coronary Artery Disease Are Associated With Colorectal Adenoma and Advanced Neoplasia.
    J Am Coll Cardiol. 2017;69:2348-2350.
    PubMed     Text format    


  16. FANAROFF AC, James SK, Weisz G, Prather K, et al
    Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial.
    J Am Coll Cardiol. 2017;69:2304-2313.
    PubMed     Text format     Abstract available


  17. LLOYD-JONES DM, Allen NB
    Childhood Cardiovascular Risk Factors and Midlife Cognitive Performance: Time to Act on Primordial Prevention.
    J Am Coll Cardiol. 2017;69:2290-2292.
    PubMed     Text format    


  18. ROVIO SP, Pahkala K, Nevalainen J, Juonala M, et al
    Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study.
    J Am Coll Cardiol. 2017;69:2279-2289.
    PubMed     Text format     Abstract available


  19. LEMESLE G, Tricot O, Meurice T, Lallemant R, et al
    Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:2149-2156.
    PubMed     Text format     Abstract available


  20. BARRABES JA, Garcia Del Blanco B, Garcia-Dorado D
    On the Stability of Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:2157-2159.
    PubMed     Text format    


    April 2017
  21. FARKOUH ME
    CABG Versus PCI for Complex Coronary Disease: Time to Close the Books.
    J Am Coll Cardiol. 2017;69:2051-2053.
    PubMed     Text format    


  22. BARWARI T, Joshi A, Mayr M
    Reply: The Complex miRNAs-p53 Signaling Network in Cardiovascular Disease.
    J Am Coll Cardiol. 2017;69:2100.
    PubMed     Text format    


  23. PATANE S
    The Complex miRNAs-p53 Signaling Network in Cardiovascular Disease.
    J Am Coll Cardiol. 2017;69:2099-2100.
    PubMed     Text format    


  24. KIM EK, Park TK, Yang JH, Song YB, et al
    Ticagrelor Versus Clopidogrel on Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:2098-2099.
    PubMed     Text format    


  25. ABDALLAH MS, Wang K, Magnuson EA, Osnabrugge RL, et al
    Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease.
    J Am Coll Cardiol. 2017;69:2039-2050.
    PubMed     Text format     Abstract available


  26. PALMERINI T, Bacchi Reggiani L, Della Riva D, Romanello M, et al
    Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting.
    J Am Coll Cardiol. 2017;69:2011-2022.
    PubMed     Text format     Abstract available


  27. POSS J, Koster J, Fuernau G, Eitel I, et al
    Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2017;69:1913-1920.
    PubMed     Text format     Abstract available


  28. PANENI F, Diaz Canestro C, Libby P, Luscher TF, et al
    The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels.
    J Am Coll Cardiol. 2017;69:1952-1967.
    PubMed     Text format     Abstract available


  29. BAVRY AA
    Non-ST-Segment Elevation Acute Coronary Syndromes: Lessons Learned Over the Last Decade.
    J Am Coll Cardiol. 2017;69:1894-1896.
    PubMed     Text format    


  30. HOEDEMAKER NP, Damman P, Woudstra P, Hirsch A, et al
    Early Invasive Versus Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial.
    J Am Coll Cardiol. 2017;69:1883-1893.
    PubMed     Text format     Abstract available


  31. JORGENSEN ME, Andersson C, Norgaard BL, Abdulla J, et al
    Functional Testing or Coronary Computed Tomography Angiography in Patients With Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:1761-1770.
    PubMed     Text format     Abstract available


  32. SOM S
    Deficiencies in Global Health Training for Cardiovascular Fellows.
    J Am Coll Cardiol. 2017;69:1748-1752.
    PubMed     Text format    


    March 2017
  33. STITZIEL NO, Khera AV, Wang X, Bierhals AJ, et al
    ANGPTL3 Deficiency and Protection Against Coronary Artery Disease.
    J Am Coll Cardiol. 2017 Mar 29. pii: S0735-1097(17)30703.
    PubMed     Text format     Abstract available


  34. NAMASIVAYAM M, McCready M, Adji A, O'Rourke MF, et al
    The Role of Heart Rate in Diastolic Coronary Perfusion and Subclinical Myocardial Ischemia.
    J Am Coll Cardiol. 2017;69:1647.
    PubMed     Text format    


  35. SPENCE JD
    Diastolic Hypotension and Myocardial Ischemia: A Reason to Remember Cuff Artifact in Blood Pressure Measurement.
    J Am Coll Cardiol. 2017;69:1646-1647.
    PubMed     Text format    


  36. CHEEZUM MK, Liberthson RR, Shah NR, Villines TC, et al
    Anomalous Aortic Origin of a Coronary Artery From the Inappropriate Sinus of Valsalva.
    J Am Coll Cardiol. 2017;69:1592-1608.
    PubMed     Text format     Abstract available


  37. O'CONNOR CM, Whellan DJ, Fiuzat M, Punjabi NM, et al
    Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial.
    J Am Coll Cardiol. 2017;69:1577-1587.
    PubMed     Text format     Abstract available


  38. YAN AT, Koh M, Chan KK, Guo H, et al
    Association Between Cardiovascular Risk Factors and Aortic Stenosis: The CANHEART Aortic Stenosis Study.
    J Am Coll Cardiol. 2017;69:1523-1532.
    PubMed     Text format     Abstract available


  39. SERBAN MC, Colantonio LD, Manthripragada AD, Monda KL, et al
    Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction.
    J Am Coll Cardiol. 2017;69:1386-1395.
    PubMed     Text format     Abstract available


  40. VERBEEK R, Sandhu MS, Hovingh GK, Sjouke B, et al
    Lipoprotein(a) Improves Cardiovascular Risk Prediction Based on Established Risk Algorithms.
    J Am Coll Cardiol. 2017;69:1513-1515.
    PubMed     Text format    


  41. SCIAHBASI A, Frigoli E, Sarandrea A, Rothenbuhler M, et al
    Radiation Exposure and Vascular Access in Acute Coronary Syndromes: The RADMatrix Trial.
    J Am Coll Cardiol. 2017 Mar 15. pii: S0735-1097(17)36042.
    PubMed     Text format     Abstract available


  42. HANNAN EL, Samadashvili Z, Cozzens K, Gesten F, et al
    Changes in Percutaneous Coronary Interventions Deemed "Inappropriate" by Appropriate Use Criteria.
    J Am Coll Cardiol. 2017;69:1234-1242.
    PubMed     Text format     Abstract available


  43. PATEL MR, Calhoon JH, Dehmer GJ, Grantham JA, et al
    ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association f
    J Am Coll Cardiol. 2017 Mar 9. pii: S0735-1097(17)30385.
    PubMed     Text format    


  44. DEBOER MD, Gurka MJ, Golden SH, Musani SK, et al
    Independent Associations Between Metabolic Syndrome Severity and Future Coronary Heart Disease by Sex and Race.
    J Am Coll Cardiol. 2017;69:1204-1205.
    PubMed     Text format    


  45. KRONISH IM, Diaz KM, Goldsmith J, Moise N, et al
    Objectively Measured Adherence to Physical Activity Guidelines After Acute Coronary Syndrome.
    J Am Coll Cardiol. 2017;69:1205-1207.
    PubMed     Text format    


  46. LIPEROTI R, Vetrano DL, Bernabei R, Onder G, et al
    Herbal Medications in Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;69:1188-1199.
    PubMed     Text format     Abstract available


  47. FREEMAN AM, Morris PB, Barnard N, Esselstyn CB, et al
    Trending Cardiovascular Nutrition Controversies.
    J Am Coll Cardiol. 2017;69:1172-1187.
    PubMed     Text format     Abstract available


  48. SHAH AD, Denaxas S, Nicholas O, Hingorani AD, et al
    Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study.
    J Am Coll Cardiol. 2017;69:1160-1169.
    PubMed     Text format     Abstract available


  49. VOGEL RA
    Biomarkers of High-Grade Coronary Stenosis: Searching for Seventies.
    J Am Coll Cardiol. 2017;69:1157-1159.
    PubMed     Text format    


  50. IBRAHIM NE, Januzzi JL Jr, Magaret CA, Gaggin HK, et al
    A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:1147-1156.
    PubMed     Text format     Abstract available


  51. GAZIANO TA
    Lifestyle and Cardiovascular Disease: More Work to Do.
    J Am Coll Cardiol. 2017;69:1126-1128.
    PubMed     Text format    


  52. LV J, Yu C, Guo Y, Bian Z, et al
    Adherence to Healthy Lifestyle and Cardiovascular Diseases in the Chinese Population.
    J Am Coll Cardiol. 2017;69:1116-1125.
    PubMed     Text format     Abstract available


  53. ESTRUCH R, Ros E
    Nutrition Intervention on Cardiovascular Risk Factors in Healthy Individuals: Glass Half Empty or Half Full?
    J Am Coll Cardiol. 2017;69:1113-1115.
    PubMed     Text format    


  54. JENKINS DJ, Boucher BA, Ashbury FD, Sloan M, et al
    Effect of Current Dietary Recommendations on Weight Loss and Cardiovascular Risk Factors.
    J Am Coll Cardiol. 2017;69:1103-1112.
    PubMed     Text format     Abstract available


    February 2017
  55. ZHAO DF, Edelman JJ, Seco M, Bannon PG, et al
    Coronary Artery Bypass Grafting With and Without Manipulation of the Ascending Aorta: A Network Meta-Analysis.
    J Am Coll Cardiol. 2017;69:924-936.
    PubMed     Text format     Abstract available


  56. MESSERLI FH, Rimoldi SF, Bangalore S, Bavishi C, et al
    Reply: Heart Rate Reduction and Cardiovascular Outcome in Hypertension.
    J Am Coll Cardiol. 2017;69:1100-1101.
    PubMed     Text format    


  57. PALATINI P
    Heart Rate Reduction and Cardiovascular Outcome in Hypertension.
    J Am Coll Cardiol. 2017;69:1099-1100.
    PubMed     Text format    


  58. MASHAYEKHI K, Neuser H, Kraus A, Zimmer M, et al
    Successful Percutaneous Coronary Intervention Improves Cardiopulmonary Exercise Capacity in Patients With Chronic Total Occlusions.
    J Am Coll Cardiol. 2017;69:1095-1096.
    PubMed     Text format    


  59. RADER DJ, Bajaj A, Khetarpal SA
    Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Risk.
    J Am Coll Cardiol. 2017;69:801-804.
    PubMed     Text format    


  60. KIM J
    Big Data, Health Informatics, and the Future of Cardiovascular Medicine.
    J Am Coll Cardiol. 2017;69:899-902.
    PubMed     Text format    


  61. JAVAHERI S, Barbe F, Campos-Rodriguez F, Dempsey JA, et al
    Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences.
    J Am Coll Cardiol. 2017;69:841-858.
    PubMed     Text format     Abstract available


  62. KOVACIC JC
    Unraveling the Complex Genetics of Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:837-840.
    PubMed     Text format    


  63. WEBB TR, Erdmann J, Stirrups KE, Stitziel NO, et al
    Systematic Evaluation of Pleiotropy Identifies 6 Further Loci Associated With Coronary Artery Disease.
    J Am Coll Cardiol. 2017;69:823-836.
    PubMed     Text format     Abstract available


  64. PECHLANER R, Tsimikas S, Yin X, Willeit P, et al
    Very-Low-Density Lipoprotein-Associated Apolipoproteins Predict Cardiovascular Events and Are Lowered by Inhibition of APOC-III.
    J Am Coll Cardiol. 2017;69:789-800.
    PubMed     Text format     Abstract available


  65. LEE PH, Park DW, Park SJ
    Reply: The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:756-757.
    PubMed     Text format    


  66. COLOMBO A, Ancona MB, Chieffo A
    The Unforgettable Cornerstone: Role of Ticlopidine in Developing Current Antithrombotic Treatment After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:755-756.
    PubMed     Text format    


  67. LANSKY AJ, Messe SR, Brickman AM, Dwyer M, et al
    Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.
    J Am Coll Cardiol. 2017;69:679-691.
    PubMed     Text format     Abstract available


  68. SINGH M, Prati F
    Exploring the Coronary Artery Wall From the Luminal Side: For Specialists or for All Cardiologists?
    J Am Coll Cardiol. 2017;69:658-660.
    PubMed     Text format    


  69. CHHATRIWALLA AK, Rader DJ
    Intracoronary Imaging, Reverse Cholesterol Transport, and Transcriptomics: Precision Medicine in CAD?
    J Am Coll Cardiol. 2017;69:641-643.
    PubMed     Text format    


  70. MOLITERNO DJ, Ziada KM
    More Time to SORT OUT Clinical Outcomes After First-Generation Drug-Eluting Stents: Related Versus Unrelated Events.
    J Am Coll Cardiol. 2017;69:625-627.
    PubMed     Text format    


  71. GALLOE AM, Kelbaek H, Thuesen L, Hansen HS, et al
    10-Year Clinical Outcome After Randomization to Treatment by Sirolimus- or Paclitaxel-Eluting Coronary Stents.
    J Am Coll Cardiol. 2017;69:616-624.
    PubMed     Text format     Abstract available


  72. BANSILAL S, Fuster V
    Reply: Medication Adherence and Cardiovascular Outcomes.
    J Am Coll Cardiol. 2017;69:599-600.
    PubMed     Text format    


  73. FARIDI KF
    Medication Adherence and Cardiovascular Outcomes.
    J Am Coll Cardiol. 2017;69:598-599.
    PubMed     Text format    


  74. CAVALCANTE R, Sotomi Y, Lee CW, Ahn JM, et al
    Reply: Percutaneous Revascularization of Left Main Disease: Could the Angiographic Follow-Up Improve the Survival?
    J Am Coll Cardiol. 2017;69:598.
    PubMed     Text format    


  75. LOZANO I, Rondan J, Vegas JM, Segovia E, et al
    Percutaneous Revascularization of Left Main Disease: Could the Angiographic Follow-Up Improve the Survival?
    J Am Coll Cardiol. 2017;69:597-598.
    PubMed     Text format    


    January 2017
  76. ELZE MC, Gregson J, Baber U, Williamson E, et al
    Comparison of Propensity Score Methods and Covariate Adjustment: Evaluation in 4 Cardiovascular Studies.
    J Am Coll Cardiol. 2017;69:345-357.
    PubMed     Text format     Abstract available


  77. SEALS AA, Chazal RA
    Promoting Initiatives in Quality of Cardiovascular Care: The Complementary Role of ACC National and State Chapters.
    J Am Coll Cardiol. 2017 Jan 19. pii: S0735-1097(17)30015.
    PubMed     Text format    


  78. ROLLINI F, Franchi F, Angiolillo DJ
    Reply: Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
    J Am Coll Cardiol. 2017;69:250-251.
    PubMed     Text format    


  79. KIM WY
    Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study.
    J Am Coll Cardiol. 2017;69:249-250.
    PubMed     Text format    


  80. BAUER L, Kern S, Rogacev KS, Emrich IE, et al
    HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.
    J Am Coll Cardiol. 2017;69:246-247.
    PubMed     Text format    


  81. VADUGANATHAN M, Harrington RA, Stone GW, Deliargyris EN, et al
    Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2017;69:176-185.
    PubMed     Text format     Abstract available


  82. FESKE SK
    A New Treatable Risk Factor for Stroke and Atherosclerotic Cardiovascular Disease?
    J Am Coll Cardiol. 2017;69:159-161.
    PubMed     Text format    


  83. ISHIKAWA K
    The Transgenic Diabetic Pig Heart: A "Sweet Heart" for Translational Cardiovascular Research.
    J Am Coll Cardiol. 2017;69:144-146.
    PubMed     Text format    


  84. VACHIAT A, McCutcheon K, Tsabedze N, Zachariah D, et al
    HIV and Ischemic Heart Disease.
    J Am Coll Cardiol. 2017;69:73-82.
    PubMed     Text format     Abstract available


  85. SARMA AA, Nkonde-Price C, Gulati M, Duvernoy CS, et al
    Cardiovascular Medicine and Society: The Pregnant Cardiologist.
    J Am Coll Cardiol. 2017;69:92-101.
    PubMed     Text format     Abstract available


  86. CHANG M, Ahn JM, Lee CW, Cavalcante R, et al
    Reply: Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2017;69:117-118.
    PubMed     Text format    


  87. FERNANDEZ-PEREIRA C, Mieres J, Rodriguez AE
    Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2017;69:116-117.
    PubMed     Text format    


  88. POURDJABBAR A, Hibbert B, Patel MP, Reeves RR, et al
    Incomplete Revascularization: The Achilles Heel of Percutaneous Coronary Interventions.
    J Am Coll Cardiol. 2017;69:115-116.
    PubMed     Text format    


    December 2016
  89. MCNAMARA RL, Spertus JA
    Reply: Risk Prediction in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:2919.
    PubMed     Text format    


  90. HUDZIK B, Lekston A, Gasior M
    Risk Prediction in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:2918-2919.
    PubMed     Text format    


  91. FORD I, Shah AS, Zhang R, McAllister DA, et al
    High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease.
    J Am Coll Cardiol. 2016;68:2719-2728.
    PubMed     Text format     Abstract available


  92. USSHER JR, Elmariah S, Gerszten RE, Dyck JR, et al
    The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease.
    J Am Coll Cardiol. 2016;68:2850-2870.
    PubMed     Text format     Abstract available


  93. MARIAN AJ, van Rooij E, Roberts R
    Genetics and Genomics of Single-Gene Cardiovascular Diseases: Common Hereditary Cardiomyopathies as Prototypes of Single-Gene Disorders.
    J Am Coll Cardiol. 2016;68:2831-2849.
    PubMed     Text format     Abstract available


  94. LAM MP, Ping P, Murphy E
    Proteomics Research in Cardiovascular Medicine and Biomarker Discovery.
    J Am Coll Cardiol. 2016;68:2819-2830.
    PubMed     Text format     Abstract available


  95. ASSIMES TL, Roberts R
    Genetics: Implications for Prevention and Management of Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68:2797-2818.
    PubMed     Text format     Abstract available


  96. FATTAH C, Nather K, McCarroll CS, Hortigon-Vinagre MP, et al
    Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:2652-2666.
    PubMed     Text format     Abstract available


  97. EGHOLM G, Kristensen SD, Thim T, Olesen KK, et al
    Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68:2622-2632.
    PubMed     Text format     Abstract available


  98. LEE MS, Gordin JS
    Bleeding Complications Before Angiography in Non-ST-Segment Elevation Acute Coronary Syndrome Patients: Insights From ACUITY.
    J Am Coll Cardiol. 2016;68:2619-2621.
    PubMed     Text format    


  99. REDFORS B, Kirtane AJ, Pocock SJ, Ayele GM, et al
    Bleeding Events Before Coronary Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    J Am Coll Cardiol. 2016;68:2608-2618.
    PubMed     Text format     Abstract available


  100. MASOUDI FA, Ponirakis A, de Lemos JA, Jollis JG, et al
    Executive Summary: Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries.
    J Am Coll Cardiol. 2016 Dec 20. pii: S0735-1097(16)37337.
    PubMed     Text format     Abstract available


  101. MASOUDI FA, Ponirakis A, de Lemos JA, Jollis JG, et al
    Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries.
    J Am Coll Cardiol. 2016 Dec 20. pii: S0735-1097(16)37338.
    PubMed     Text format     Abstract available


  102. PATEL MR, Calhoon JH, Dehmer GJ, Grantham JA, et al
    ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Th
    J Am Coll Cardiol. 2016 Dec 14. pii: S0735-1097(16)36782.
    PubMed     Text format    


  103. EGBE AC, Warnes CA
    Cardiovascular Adverse Events After Aortic Valve Replacement in Mixed Aortic Valve Disease: Beyond Ejection Fraction.
    J Am Coll Cardiol. 2016;68:2591-2593.
    PubMed     Text format    


  104. VAN KRUIJSDIJK RC, van der Graaf Y, Algra A, de Borst GJ, et al
    The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease.
    J Am Coll Cardiol. 2016;68:2588-2589.
    PubMed     Text format    


  105. BARWARI T, Joshi A, Mayr M
    MicroRNAs in Cardiovascular Disease.
    J Am Coll Cardiol. 2016;68:2577-2584.
    PubMed     Text format     Abstract available


  106. KULANDAVELU S, Karantalis V, Fritsch J, Hatzistergos KE, et al
    Pim1 Kinase Overexpression Enhances ckit+ Cardiac Stem Cell Cardiac Repair Following Myocardial Infarction in Swine.
    J Am Coll Cardiol. 2016;68:2454-2464.
    PubMed     Text format     Abstract available


  107. GORE MO, McGuire DK
    A Test in Context: Hemoglobin A1c and Cardiovascular Disease.
    J Am Coll Cardiol. 2016;68:2479-2486.
    PubMed     Text format     Abstract available


  108. ARBAB-ZADEH A, Fuster V
    The Risk Continuum of Atherosclerosis and its Implications for Defining CHD by Coronary Angiography.
    J Am Coll Cardiol. 2016;68:2467-2478.
    PubMed     Text format     Abstract available


    November 2016
  109. GESKE JB, Anavekar NS, Nishimura RA, Oh JK, et al
    Differentiation of Constriction and Restriction: Complex Cardiovascular Hemodynamics.
    J Am Coll Cardiol. 2016;68:2329-2347.
    PubMed     Text format     Abstract available


  110. NDREPEPA G, Colleran R, Braun S, Cassese S, et al
    High-Sensitivity Troponin T and Mortality After Elective Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:2259-2268.
    PubMed     Text format     Abstract available


  111. BARBATO E, Toth GG, Johnson NP, Pijls NH, et al
    A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.
    J Am Coll Cardiol. 2016;68:2247-2255.
    PubMed     Text format     Abstract available


  112. BEYGUI F, Montalescot G
    Reply: Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction: Who Benefits?
    J Am Coll Cardiol. 2016;68:2241-2242.
    PubMed     Text format    


  113. WEIR RA, Petrie CJ
    Mineralocorticoid Receptor Antagonism in Acute Myocardial Infarction: Who Benefits?
    J Am Coll Cardiol. 2016;68:2240-2241.
    PubMed     Text format    


  114. DWECK MR, Williams MC, Moss AJ, Newby DE, et al
    Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease.
    J Am Coll Cardiol. 2016;68:2201-2216.
    PubMed     Text format     Abstract available


  115. MOSS AJ
    Multicenter Cardiovascular Studies and Trials: Lessons Learned From 35 Years of Productive Collaboration.
    J Am Coll Cardiol. 2016;68:2232-2234.
    PubMed     Text format    


  116. DYKUN I, Lehmann N, Kalsch H, Mohlenkamp S, et al
    Statin Medication Enhances Progression of Coronary Artery Calcification: The Heinz Nixdorf Recall Study.
    J Am Coll Cardiol. 2016;68:2123-2125.
    PubMed     Text format    


  117. FENTANES E, Wessman D, Villines TC, Steel KE, et al
    Serving to Heal and Honored to Serve: An Insight Into Military Cardiovascular Fellowship.
    J Am Coll Cardiol. 2016;68:2118-2121.
    PubMed     Text format    


  118. FLEGO D, Liuzzo G, Weyand CM, Crea F, et al
    Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications.
    J Am Coll Cardiol. 2016;68:2107-2117.
    PubMed     Text format     Abstract available


  119. KO DT, Alter DA, Guo H, Koh M, et al
    High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.
    J Am Coll Cardiol. 2016;68:2073-2083.
    PubMed     Text format     Abstract available


  120. FRANKLIN SS, Thijs L, Asayama K, Li Y, et al
    The Cardiovascular Risk of White-Coat Hypertension.
    J Am Coll Cardiol. 2016;68:2033-2043.
    PubMed     Text format     Abstract available


  121. RACCA V, Rovaris M, Vaini E, Cavarretta R, et al
    6-Month Effects of Fingolimod on Indexes of Cardiovascular Autonomic Control in Multiple Sclerosis.
    J Am Coll Cardiol. 2016;68:2027-2029.
    PubMed     Text format    


  122. FEINSTEIN MJ, Mitter SS, Yadlapati A, Achenbach CJ, et al
    HIV-Related Myocardial Vulnerability to Infarction and Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68:2026-2027.
    PubMed     Text format    


  123. HATA R, Kadota K, Hyodo Y, Otsuru S, et al
    TCT-243 Second generation drug-eluting stents or coronary bypass surgery in patients with three-vessel coronary disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  124. SINGH S, Ahsan L, Grayver E, Rosen S, et al
    TCT-197 Women Received Delayed Admission ECG with Typical Symptom Presentation in ST-Segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  125. YUDI M, Andrianopoulos N, O'Brien J, Selkrig L, et al
    TCT-195 Predictors of Recurrent Acute Coronary Syndrome Hospitalisations Following Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  126. REMKES W, Roolvink V, Rasoul S, Dambrink JH, et al
    TCT-193 Zotarolimus eluting stent compared with GENOUS stent in patients with ST-elevation myocardial infarction undergoing primary PCI.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  127. GAAFAR A, Al Kabbany A, El Shedoudy S, Badr S, et al
    TCT-190 The value of QRS duration as a marker of myocardial reperfusion in patient with acute ST-segment elevation myocardial infarction treated with primary percutaneous intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  128. SHIN H, Jang JS, Jin HY, Seo JS, et al
    TCT-192 Combined Use of Neutrophil to Lymphocyte Ratio and C-Reactive Protein to predict Clinical Outcomes in Acute Myocardial Infarction Patients undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  129. MAHMOUD A, Elgendy A, Mansoor H, Mojadidi M, et al
    TCT-191 Intravenous beta-blockers for Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  130. BAEK JY, Rha SW, Choi BG, Byun JK, et al
    TCT-189 Comparison of 5-year Clinical Outcomes between Stabilized Acute Myocardial Infarction Patients following Percutaneous Coronary Intervention and the Patients with Angina Pectoris.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  131. ELIAS J, van Dongen I, Hoebers L, Ouweneel D, et al
    TCT-188 The impact of the location on left ventricular function in ST-elevation Myocardial Infarction patients with a chronic total occlusion in a non-infarct related artery treated with percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  132. ANANTHA NARAYANAN M, Reddy YN, Gujjula N, Anugula D, et al
    TCT-186 Delayed versus immediate stenting strategy in ST segment elevation myocardial infarction - A meta analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  133. JANG JH, Kim DK, Song PS, Kim DI, et al
    TCT-185 Influence of total ischemic time on clinical outcomes and efficacy of manual thrombus aspiration during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Analysis from the POST trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  134. RHEE TM, Lee JM, Hwang D, Park J, et al
    TCT-183 Deferred versus Conventional stent implantation in patients with acute ST-segment elevation myocardial infarction: an updated meta-analysis of 10 Studies.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  135. BARDOOLI F, McAlindon E, Littlejohns B, Suleiman MS, et al
    TCT-184 Early changes in circulating miRNA 133a are indicative of cardiac remodelling after 3 months in patients presenting with acute ST elevation myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  136. GIUSTINO G, Mehran R, Kirtane A, Redfors B, et al
    TCT-181 Temporal Differences in Ischemic and Bleeding Risks after Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  137. SCHENK R, Nix D
    TCT-180 Impact of the novel DPP-IV-inhibitor Dutogliptin in combination with G-CSF on survival rates and cardiac remodelling after acute myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  138. HER AY, Rha SW, Kim YH, Choi BG, et al
    TCT-182 Impact of Gender and Age on Long-term Mortality in Acute Myocardial Infarction Patients with Anemia.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  139. MOVAHED MR, Hashemzadeh M
    TCT-177 Obesity is independently associated with occurrence of ST elevation myocardial infarction with steady decline of this association over the recent years.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  140. SGUEGLIA G, Gioffre G, De Santis A, D'Errico F, et al
    TCT-178 Feasibility and safety of the "the one small catheter only" (TOSCO) strategy in patients with ST elevation myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  141. HIGASHIHARA T, Dote K, Kato M, Sasaki S, et al
    TCT-175 Myocardial Wash Grade in Evaluation of Reperfusion Therapy in Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  142. YUDI M, Farouque O, Ajani A, Brennan A, et al
    TCT-176 Clinical Outcomes of Patients Receiving Pre-treatment with Dual Anti-platelet Therapy in ST-Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  143. BESSONOV I, Zyrianov I, Kuznetsov V, Sapozhnikov S, et al
    TCT-174 Impact of Direct Stenting on In-Hospital Outcomes in Patients with ST-Elevation Myocardial Infarction and Hyperglycemia.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  144. LARSON D, Garberich R, Lips D, Burke MN, et al
    TCT-173 Safety of Very Early (< 3hrs) Routine Percutaneous Coronary Intervention after Fibrinolysis in ST-segment Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  145. VAN HOUWELINGEN KG, van der Heijden L, Lam MK, Lowik M, et al
    TCT-170 Clinical Outcome After Myocardial Infarction Treated With Resolute Integrity and Promus Element Stents: Insights From DUTCH PEERS (TWENTE II) Randomized Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  146. YAMADA T, Mizuguchi Y, Takahashi A, Shibutani H, et al
    TCT-169 The impact of a door-to-balloon time of less than 30 minutes on the in-hospital mortality in patients with ST elevation myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  147. GIUSTINO G, Redfors B, Brener S, Kirtane A, et al
    TCT-166 Correlates and Prognostic Impact of New-Onset Heart Failure after ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Insights from the INFUSE-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  148. LEE JH, Choi KU, Kim U, Lee CH, et al
    TCT-167 Clinical impact of body mass index in old age patients with acute myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  149. DE WAARD G, Fahrni G, de Wit D, Kitabata H, et al
    TCT-165 Hyperemic microvascular resistance is a predictor of clinical outcome after revascularization for acute myocardial infarction: A patient-level pooled analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  150. VLACHOJANNIS G, Paradies V, Hofma SH, Togni M, et al
    TCT-161 5 years follow-up of biolimus eluting stents versus everolimus eluting in ST-segment elevation myocardial infarction presenting patients: Results from Compare II trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  151. SAIB A, Payot L, Kerneis M, Barthelemy O, et al
    TCT-160 Impact of admission during ON vs. OFF hours in unselected ST-Elevation Myocardial Infarction Patients treated with Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  152. VILLABLANCA P, Makkiya M, Mohananey D, Lesniak-Sobelga A, et al
    TCT-159 Impact of Staged versus One-Time Multivessel Percutaneous Intervention in ST-elevation Myocardial Infarction: A Meta-analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  153. LOBO MG, Dipp T, Petry I, Schmidt K, et al
    TCT-158 Treating Periodontal Disease in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  154. VELAGAPUDI P, Turagam M, Katta N, Mittal M, et al
    TCT-154 Multivessel Revascularization versus Culprit Vessel Only Revascularization in Patients with ST-Elevation Myocardial Infarction and multivessel disease: An Updated Meta-analaysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  155. SONG Y, Ma YL, Zhang JH, Tang XF, et al
    TCT-155 Prognostic Impact of the Residual SYNTAX Score on 2-years Outcomes in Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  156. JANG WJ, Song YB, Yang JH, Gwon HC, et al
    TCT-152 Clinical Significance of Post-infarct Fever in ST-segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  157. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-153 Acute Stroke During Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  158. GUTTMANN O, Perera D, Jain A, Mathur A, et al
    TCT-146 Routine Aspiration thrombectomy is associated with increased stroke rates during primary percutaneous coronary intervention for myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  159. HAMZA M, Shehata M
    TCT-147 Local intracoronary delivery of eptifibatide plus verapamil via thrombus aspiration catheter to prevent No-reflow in acute ST elevation myocardial infarction patients with large thrombus burden.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  160. VERGARA R, Valenti R, Migliorini A, Parodi G, et al
    TCT-145 Rheolytic Thrombectomy for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  161. VOUDRIS K, Vidovich M
    TCT-143 Outcomes of Percutaneous Coronary Intervention for Acute Myocardial Infarction in patients with history of Malignancy.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  162. VOUDRIS K, Vidovich M
    TCT-141 Percutaneous Coronary Intervention (PCI) for Acute Myocardial Infarction in patients with Systemic lupus erythematosus: analysis from Nationwide Inpatient Sample (NIS).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  163. DE LA TORRE HERNANDEZ JM, Gomez Hospital JA, Brugaletta S, Baz JA, et al
    TCT-137 Influence of non-culprit lesions management on outcomes in patients over 75 years old with ST elevated myocardial infarction. Results from the ESTROFA MI+75 nation-wide registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  164. HAMZA M, Elgendy I
    TCT-139 A randomized trial of complete versus culprit-only revascularization during primary percutaneous coronary intervention in diabetic patients with acute ST elevation myocardial infarction and multi vessel disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  165. CID ALVAREZ AB, Galvao Braga C, Redondo Dieguez A, Trillo R, et al
    TCT-138 Multivessel versus culprit-only percutaneous coronary intervention in ST-segment elevation myocardial infarction: analysis of a 8 year-all-comers registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  166. MERAJ P, Maini B, Mascari P, Jauhar R, et al
    TCT-131 Survival Benefit when using Impella 2.5 Percutaneous LVAD prior to PCI of Unprotected Left Main Culprit Vessel in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  167. LEURENT G, Garlantezec R, Auffret V, Filippi E, et al
    TCT-130 Complete Myocardial Revascularisation is not Associated with a Better Prognosis in Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction. Insight from the multicenter prospective ORBI registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  168. BASIR M, Khandelwal A, Dixon S, Moses J, et al
    TCT-121 Mechanical Circulatory Support in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Insights from the cVAD Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  169. VERGARA R, Valenti R, Migliorini A, Parodl G, et al
    TCT-119 A New Risk Score to Predict Long-Term Cardiac Mortality in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock and Treated with Primary Percutaneous Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  170. RATHOD K, Mathur A, Wragg A, O'Mahony C, et al
    TCT-117 Impact of Intra-aortic Balloon Pump use on mortality in patients with cardiogenic shock treated with Primary Percutaneous Coronary Intervention: An Observational Study of 21,210 patients with ST-Elevation Myocardial Infarction from the London
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  171. CAVALCANTE R, Sotomi Y, Suwannasom P, Lee CW, et al
    TCT-67 Impact of the SYNTAX score in patients with diabetes and left-main and/or multivessel coronary disease: a pooled analysis of individual patient level data from the SYNTAX, PRECOMBAT and BEST trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  172. ESTEVEZ R, Benito-Gonzalez T, Gualis-Cardona J, Romero-Roche L, et al
    TCT-643 Percutaneous Mitral Valve Repair for Acute Mitral Regurgitation Following an Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  173. TERASHITA D, Morino Y, Otake H, Kikuchi T, et al
    TCT-563 Early vascular responses to everolimus-eluting cobalt-chronium stent for the treatment of ST-elevation acute myocardial infarction: the results of the MECHANISM-AMI study 3-months OCT follow-up cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  174. OH JH, Choe JC, Ahn J, Sup PJ, et al
    TCT-558 Comparison of in-hospital outcome between intracoronary imaging-guided versus angiography-guided percutaneous coronary intervention in patient with acute myocardial infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  175. ANTONSEN L, Christiansen E, Maeng M, Ravkilde J, et al
    TCT-551 Impact of Late Acquired Malapposition after Biolimus-eluting and Sirolimus-eluting Stent Implantation on 5-year Clinical Outcomes Following ST-segment Elevation Myocardial Infarction: Intravascular Ultrasound Analysis from the SORT OUT V Trial
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  176. ANTONSEN L, Christiansen E, Maeng M, Ravkilde J, et al
    TCT-550 Influence of 12-month Late Incomplete Stent Apposition after Biolimus-eluting and Sirolimus-eluting Stent Implantation on 5-year Clinical Outcomes Following ST-segment Elevation Myocardial Infarction: Insigths from the SORT OUT V Trial Intrava
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  177. SALINAS P, Mejia-Renteria H, Herrera-Nogueira R, Del Trigo M, et al
    TCT-50 Impact of a bifurcation culprit lesion in ST elevation myocardial infarction: procedural success, clinical outcome and 5-year follow-up.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  178. WINDECKER S, Asano T, Raber L, Brugaletta S, et al
    TCT-49 Two-year clinical outcome of Everolimus-eluting bioresorbable scaffold vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myoc
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  179. GUAN C, Xu B, Gao R
    TCT-461 Comparison of Two Biodegradable Polymer-Based Sirolimus-Eluting Stents with Varying Elution and Absorption Kinetics in Acute Myocardial Infarction Patients: A Subgroup Analysis of PANDA III Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  180. AL NOORYANI A, Elabbassi W, Markovic M, Bhatia A, et al
    TCT-429 Safety, feasibility and performance of the first 300 everolimus-eluting bioresorbable scaffold PCI in an all-comers population with ischemic heart disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  181. WIEBE J, Harada Y, Hoppmann P, Colleran R, et al
    TCT-414 Two-year outcomes of patients with acute coronary syndrome versus stable coronary disease undergoing bioresorbable scaffold implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  182. TOMANIAK M, Fam JM, Felix C, Geuns RV, et al
    TCT-412 Long-term clinical outcomes after implantation of everolimus-eluting bioresorbable vascular scaffold in patients with acute myocardial infarction. 24-month clinical follow-up of the BVS STEMI First Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  183. BRUGALETTA S, Gori T, Low A, Tousek P, et al
    TCT-404 ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-year results from a propensity score matched comparison.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  184. KARAMASIS G, Al-Janabi F, Mohdnazri S, Jagathesan R, et al
    TCT-386 Incidence and prevention of contrast induced acute kidney injury in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  185. PATEL N, Patel N, Arora S, Alfonso C, et al
    TCT-380 Outcomes of Patients with Acute Myocardial Infarction in Moderate to Severe Chronic Kidney Disease in the United States.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  186. SOUZA MT, Barbosa A, Souza R, Dotta G, et al
    TCT-366 Predictors of major complications secondary to cardiac catheterization through femoral access in ST elevation in acute myocardial infarction during Pharmaco-Invasive Therapy.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  187. YEE J, Higgins J, Kumar V, Anuwatworn AS, et al
    TCT-363 Patient Characteristics Influencing Physician Selection of Radial vs. Femoral Access in patients presenting emergently with ST-Elevation Myocardial Infarction.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  188. AL NOORYANI A, Elabbassi W, Markovic M, Kerfes G, et al
    TCT-356 The use of robotic-assisted PCI for the treatment of patients with ischemic heart disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  189. JIANG L, Yuan J, Gao R, Xu B, et al
    TCT-346 Impact of anemia after coronary stenting on long-term outcomes of patients with coronary disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  190. HERMANIDES R, Kedhi E, Kennedy M, van Dijk P, et al
    TCT-266 Impact of elevated glycosylated hemoglobin (HbA1c) on admission on long-term Mortality in Patients with Unknown Diabetes Mellitus Presenting with acute myocardial infarction (STEMI or NSTEMI).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  191. CHO MS, Kang DY, Do U, Hong JA, et al
    TCT-258 Clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention for multi-vessel coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  192. HE Y, Li Y, Zhang D, Xu B, et al
    TCT-254 A Novel Tool for Risk Prediction of PEriprocedural MyocaRdial InFarction after PErcutaneous Coronary InTervention: the PERFECT Score System.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  193. KUMAR A, Wagener J, Jones S, Wojdyla D, et al
    TCT-244 Lower rates of repeat revascularization among patients with prior coronary artery bypass grafting is partly due to lack of adequate target vessels.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  194. JINNOUCHI H, Kuramitsu S, Ando K
    TCT-240 Long-Term Clinical Outcome of Drug-Eluting Stent Following Rotational Atherectomy for Heavily Calcified Lesions.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  195. CHO MS, Do U, Lee K, Hong JA, et al
    TCT-242 Temporal Changes in Outcomes after Stent or Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease by Diabetes Status.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  196. AMEMIYA K, Yamamoto MH, Maehara A, Oyama Y, et al
    TCT-239 Effect of Cutting Balloon after Rotablator in Severely Calcified Coronary Artery Lesions Assessed by Optical Frequency Domain Imaging.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  197. REDFORS B, Genereux P, Maehara A, Kirtane A, et al
    TCT-237 Outcomes After Successful PCI of Severely Calcified Lesions Using Rotational Atherectomy, Cutting Balloon, or Balloon Angioplasty only Before Second-Generation Drug-Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  198. KARACSONYI J, Martinez-Parachini JR, Alame A, Danek BA, et al
    TCT-233 Contemporary Use of Laser during Percutaneous Coronary Intervention: Initial Results from the Laser Veterans Affairs (LAVA) Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  199. EDES IF, Ruzsa Z, Szabo G, Lux A, et al
    TCT-228 Rotational atherectomy of malapposed, undilatable coronary stents: fact or fiction?
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  200. MCGREW A, Singh M, Stahl J, Yoos J, et al
    TCT-230 Rotational Atherectomy vs Orbital Atherectomy in Calcified Coronary Artery Disease: A Contemporary Retrospective Comparative Analysis (ROCC study).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  201. BURGOS JM, Gonzalez BS, Canton T, Lazaro-Fernandez E, et al
    TCT-226 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab (TOLEDO 1).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  202. KADRO W, Muhanna J, Turkmani M, Rumman R, et al
    TCT-225 Cliopidogril And Ticagrelor Highlights on Silent Holter Ambulatory Myocardial Ischemia (CATH SHAMI study).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  203. FAGGIONI M, Chandrasekhar J, Aquino M, Vogel B, et al
    TCT-224 Real world use of antithrombotic regimens after percutaneous coronary intervention in patients with atrial fibrillation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  204. LEE CH, Kwon O, Do U, Hong JA, et al
    TCT-223 A randomized, placebo controlled, double-blind, phase 4 study to evaluate efficacy and safety of triple anti-platelet therapy compared with dual antiplatelet therapy in patients treated with drug-eluting stent for coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  205. HWANG D, Lee JM, Rhee TM, Park J, et al
    TCT-222 Clinical Outcomes of Dual Antiplatelet Therapy after Coronary Stenting in Patients with Chronic Kidney Disease: Patient-level Meta-analysis of 4 Randomized Clinical Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  206. FARHAN S, Baber U, Chandrasekhar J, Sartori S, et al
    TCT-221 Predictors of optimal medical therapy on discharge after percutaneous coronary intervention for acute coronary syndrome: An analysis of the PROMETHEUS registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  207. FAGGIONI M, Chandrasekhar J, Baber U, Vogel B, et al
    TCT-219 Influence Of Anemia On Physician-Recommended DAPT Discontinuation After Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  208. ROSSINGTON J, Hoye A, Spurgeon B, Aznaouridis K, et al
    TCT-220 Is Inhibition of Platelet Aggregation by Endogenous Endothelial Platelet Antagonists Enhanced by Oral Ticagrelor Mediated P2Y12 Blockade in Patients With Coronary Artery Disease?
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  209. MAHMOUD A, Elgendy I
    TCT-218 Factors influencing the risk of major bleeding with bivalirudin compared with unfractionated heparin in percutaneous coronary intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  210. MAHMOUD A, Elgendy I
    TCT-215 Meta-analysis of randomized trials comparing bivalirudin versus unfractionated heparin for percutaneous coronary intervention through trans-radial approach.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  211. LAU J, Alcock R, Cherry J, Yong A, et al
    TCT-212 Application of the DAPT score to a contemporary Percutaneous Coronary Intervention cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  212. GIUSTINO G, Chieffo A, Palmerini T, Valgimigli M, et al
    TCT-213 Efficacy and Safety of Long- Versus Short-Term Dual Antiplatelet Therapy Following Complex Percutaneous Coronary Intervention with Drug-Eluting Stents: A Collaborative Patient-Level Pooled Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  213. SAAD M, Gamal A, Nairooz R
    TCT-210 Bivalirudin versus Heparin in Women undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Clinical Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  214. MURANISHI H, Yamaji K, Yamaji Y, Ando K, et al
    TCT-209 Optimal duration of dual antiplatelet therapy after left main coronary artery stenting: A retrospective multicenter AOI LMCA stenting registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  215. HARADA Y, Lohaus R, Mayer K, Emmer R, et al
    TCT-207 Extended validation of a decision tool (DAPT score) in patients randomized to 6 or 12 months dual antiplatelet therapy after percutaneous coronary intervention with predominantly second-generation drug-eluting stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  216. FERRI LA, Chieffo A, Giustino G, Frasheri A, et al
    TCT-204 Optimal duration of dual antiplatelet therapy (DAPT) after second generation drug-eluting stent (DES) implantation in elderly patients: the SECURITY-ELDERLY substudy.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  217. PHILIP F, Anderson S, Ram S, Bommer W, et al
    TCT-202 Interaction between choice of anticoagulation, antiplatelet therapy and access site on mortality and bleeding after percutaneous coronary intervention: Insights from the California NCDR registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  218. ANANTHA NARAYANAN M, Gujjula N, Anugula D, Reddy YN, et al
    TCT-203 Dual versus triple anti thrombotic therapy in Acute Coronary Syndromes - A meta analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  219. EMBACHER M, Kosmidou I, Dordi R, Redfors B, et al
    TCT-200 Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes by Culprit Coronary Artery in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  220. ROBERTS L, Parfrey S, Andrianopoulos N, Teh A, et al
    TCT-187 Safety of Early Discharge Following Percutaneous Coronary Intervention (PCI) for STEMI.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  221. HAHN JY, Kim EK, Park TK, Lee JM, et al
    TCT-171 Effect of Ticagrelor Compared with Clopidogrel on Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  222. NARAYANAN MA, Reddy YN, Anugula D, Gujjula N, et al
    TCT-156 Bivalirudin versus Heparin in Primary Percutaneous Coronary Intervention- a Meta analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  223. CID ALVAREZ AB, Redondo Dieguez A, Galvao Braga C, Trillo R, et al
    TCT-149 Impact of Chronic Total Occlusion in a Non-Infarct-related Artery on clinical outcomes in patients undergoing Primary Percutanous Coronary Intervention: analysis of a 8 year-all-comers prospective registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  224. AZZALINI L, Dautov R, Ojeda S, Bellini B, et al
    TCT-13 Outcomes of chronic total occlusion percutaneous coronary intervention according to dissection/re-entry versus wire escalation techniques.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  225. JONES D, Rathod K, Weerackody R, Wragg A, et al
    TCT-14 Specialist Chronic Total Occlusion (CTO) Programmes and Outcomes after CTO Percutaneous Coronary Interventions: An observational study of 5,496 patients from the Pan-London CTO Cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  226. DANEK BA, Karatasakis A, Karmpaliotis D, Alaswad K, et al
    TCT-15 Use of Antegrade Dissection Re-entry in Coronary Chronic Total Occlusion Percutaneous Coronary Intervention in a Contemporary Multicenter Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  227. KOIFMAN E, Garcia-Garcia HM, Kiramijyan S, Negi S, et al
    TCT-144 Impact of Thrombus Aspiration in Primary Percutaneous Coronary Intervention On Long-Term Outcome.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  228. VOUDRIS K, Vidovich M
    TCT-142 Temporal Trends in Incidence of Acute Myocardiacl Infarction in Patients With Malignancy Undergoing Percutaneous Coronary Intervention (PCI).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  229. SHAVELLE D, Kapasi N, Banerjee S, Schreiber T, et al
    TCT-127 Prior Coronary Artery Bypass Graft Surgery and Hemodynamically Supported High Risk Percutaneous Coronary Intervention: Observations from The PROTECT II Randomized Trial and The cVAD Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  230. SHARMA S, Palacios I, O'Neill W, Witzke CF, et al
    TCT-124 Predictors of the Need for Continuous Impella Support in High Risk Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  231. FLAHERTY M, Pant S, Kilgore T, Dassanayaka S, et al
    TCT-123 Impella 2.5 Support Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  232. PATEL N, Patel N, Arora S, Badheka A, et al
    TCT-118 Sex Differences in Coronary Angiography, Percutaneous Coronary Intervention, and Outcomes During Hospitalization After Out of Hospital Cardiac Arrest with Ventricular Fibrillation or Pulseless Ventricular Tachycardia.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  233. ANSARI M, Garcia D
    TCT-116 Elective Use of Intra-Aortic Balloon Pump For High-Risk Percutaneous Coronary Intervention For ACS: Meta-Analysis of RCT's.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  234. CHO S, Cho GY, Kim D, Lim SH, et al
    TCT-115 Clinical features and Outcomes in patients with Acute Coronary Syndrome Complicated by Cardiogenic Shock supported with Extracorporeal Membrane Oxygenation, Single Center Experience.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  235. CHANDRASEKHAR J, Baber U, Sartori S, Aquino M, et al
    TCT-111 Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  236. REDFORS B, Volz S, Angeras O, Haraldsson I, et al
    TCT-107 Ticagelor is not superior to clopidogrel in patients with acute coronary syndrome - A report from SCAAR.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  237. GARCIA E, Hong S, Cho SA, Cho JY, et al
    TCT-108 Comparison of Ticagrelor versus Prasugrel on Inflammation, Vascular Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients with Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting: Prospective,
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  238. RAFIQUE A, Chandrasekhar J, Baber U, Sartori S, et al
    TCT-105 Prevalence of prasugrel use and associations between type of acute coronary syndrome and 1-year clinical outcomes.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  239. FALLESEN CO, Christiansen E, Botker HE, Raungaard B, et al
    TCT-106 Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer In Patients with Acute Coronary Syndromes. From the SORT OUT VII Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  240. SHAH R, Hwang IH, Nayyar M, Slomka T, et al
    TCT-104 Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  241. PRAKASH R, Starovoytov A, Aymong E, Saw J, et al
    TCT-103 Angiographic Healing of Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  242. YONG C, Abnousi F, Asch S, Heidenreich P, et al
    TCT-100 Asians suffer the highest in-hospital mortality rates after acute coronary syndrome despite high use of early invasive procedures.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  243. SHAH R, Hwang IH, Nayyar M, Christian E, et al
    TCT-102 Association Between Operator Experience with Access Type in Percutaneous Coronary Intervention and Outcomes in Patients with Acute Coronary Syndrome: A Network Meta-Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  244. SAW J, Starovoytov A, Zhao Y, Peng D, et al
    TCT-101 Predictors for Recurrent Dissection after Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  245. WESTRA J, Tu S, Nissen L, Winther S, et al
    TCT-10 Physiological testing of coronary artery stenosis by computation of invasive coronary angiography. The wire-free functional imaging (WIFI-II) study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  246. KOVARNIK T, Chen Z, Wahle A, Fukumoto Y, et al
    TCT-96 Progression of coronary atherosclerosis despite lipid-lowering therapy in diabetic patients compared to non-dibetic ones. Study with 3D intravascular ultrasound and virtual histology.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  247. UMMAN S, Umman B, Aslanger E, Atici A, et al
    TCT-95 The interplay between features of plaque vulnerability and hemodynamic relevance of coronary artery stenoses.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  248. SCHUURMAN AS, Kardys I, Oemrawsingh R, Diletti R, et al
    TCT-93 Near-infrared spectroscopy derived Lipid Core Burden Index predicts major adverse cardiovascular events in patients with coronary artery disease during 4.3 year follow-up.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  249. KHARLAMOV A
    TCT-854 Cardiovascular Burden and Percutaneous Interventions in Russia: Epidemiological Update and Results of National Screening.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  250. LACOMBE A, O'Brien A, Bundy J, Clarey A, et al
    TCT-852 Impact of Robotics and a Suspended Lead Suit on Physician Radiation Exposure During Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  251. TELLEZ A, Gasior P, Shanmuganayagam D, Conditt G, et al
    TCT-841 Combined Coronary Artery Imaging for Plaque Characterization in Preclinical Studies: An OCT-IVUS-Histological Study of the Familial Hypercholesterolemic Swine Model.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  252. BUSZMAN P, Michalak M, Pruski M Jr, Jelonek M, et al
    TCT-837 Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  253. YAHAGI K, Kolodgie F, Cheng D, Acampado E, et al
    TCT-836 Endothelial Cell Coverage and Inflammation Comparing COBRA Polyzene-F (PzF) Coated Stent to Durable Fluoropolymer and Biodegradable Polymer Drug-Eluting Stents in a Rabbit Model.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  254. SCHIAVONE A, Abunassar C, Zhao L, Hossainy S, et al
    TCT-834 Bioresorbable Scaffolds versus Metallic Drug Eluting Stents - Comparison of Predicted Arterial Stress after Simulated Deployment in Concentric and Eccentric Coronary Lesions.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  255. YAHAGI K, Kolodgie F, Cheng D, Acampado E, et al
    TCT-835 Endothelial Function Assessed by Expression of Adherens Junctions and Inflammation between Durable and Biodegradable Polymer Drug-Eluting Stents in the Rabbit Iliofemoral Model.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  256. VALENCIA A, Gasior P, Cheng Y, Xia J, et al
    TCT-832 In Vivo Biomechanical Performance of Thin Strut Sirolimus-Eluting Coronary Scaffold, Regular-Strut Scaffolds and Bare Metal Stents in Normal Porcine Coronary Arteries.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  257. VALENCIA A, Gasior P, Cheng Y, Xia J, et al
    TCT-831 Novel Thin Strut (100 mum) Ultra-High Molecular Weight PLLA Sirolimus-Eluting Bioresorbable Scaffold: A Comparative Preclinical Evaluation in Porcine Coronary Arteries.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  258. GASIOR P, Cheng Y, Xia J, Valencia A, et al
    TCT-829 Biomechanical Behavior and Healing Response of a Novel Thin Strut Sirolimus Eluting Bioresorbable Scaffold Overexpanded up to 0.75 mm Beyond Nominal Compliance Chart Diameters in Porcine Coronary Artery Model.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  259. GOGAS BD, Kumar S, Benham J, Panchal D, et al
    TCT-828 Very Late Vasomotor Responses and Gene Expression Profiles of Porcine Coronary Arteries at 4 Years after Deployment of the Everolimus-eluting Bioresorbable Vascular Scaffold and the Everolimus-eluting Metallic Xience V stent.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  260. CHAKRAVARTY T, Makkar R, Henry T, Kittleson M, et al
    TCT-820 Multivessel Intracoronary Infusion of Allogeneic Cardiosphere Derived Cells in Dilated Cardiomyopathy: Long Term Outcomes of the Dilated Cardiomyopathy Intervention with Allogeneic Myocardially-Regenerative Cells (DYNAMIC Trial).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  261. GHIRARDI G, Ferrari C, Pontone G, Trabattoni D, et al
    TCT-809 Stenting for the treatment of pulmonary vein stenosis after atrial fibrillation radiofrequency catheter ablation: initial experience with peripheral stents plus drug-coated balloons and coronary drug-eluting stents.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  262. ISHIHARA T, Iida O, Kozuki A, Shinke T, et al
    TCT-785 Association between the Platelet Reactivity under Clopidogrel Treatment and the Severity of Angioscopic Intra-stent Thrombus Following Drug-eluting Stent Implantation in the Femoropopliteal Artery.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  263. GASIOR P, Cheng Y, Valencia A, McGregor J, et al
    TCT-776 Vascular Healing Response after Implantation of a Novel Fluoropolymer-Coated Paclitaxel-Eluting Peripheral Stent: a Comparative Drug-Eluting Stent Study in a Familial Hypercholesterolemic Swine Model of Balloon-Injured Femoral Arteries.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  264. YOON HJ, Oh JH, Kim KB, Bae HJ, et al
    TCT-76 Temporal change of in-stent thrombus immediately after percutaneous coronary intervention within 5 minutes using optical coherence tomography.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  265. CHETCUTI S, Kleiman N, Matthews R, Popma J, et al
    TCT-743 Percutaneous Coronary Intervention after Self-Expanding Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  266. YAMAMOTO MH, Yamashita K, Matsumura M, Ebara S, et al
    TCT-73 Serial Three-Vessel Optical Coherence Tomography and Intravascular Ultrasound Analysis of Changing Morphologies Associated of Plaque Progression in Patients With Stable Angina Pectoris.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  267. SMITS P, Ben-Yehuda O, Kosmidou I, Ozan MO, et al
    TCT-71 The NIREUS Randomized Trial: 1-Year Results of the BioNIR Ridaforolimus-Eluting Coronary Stent System (BioNIR) EUropean Angiography Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  268. GOMEZ MENCHERO A, Balaguer J, Lopez Otero D, Piris RM, et al
    TCT-72 Short and medium-term clinical outcome of amphilimus polymer-free drug-eluting stent in diabetic patients: An all-comers multicenter spanish registry. (Control-8 registry).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  269. WONG SC, Voudris K, Bergman G, Minutello R, et al
    TCT-709 Trans-apical Transcatheter Aortic Valve Replacement in Patients with History of Coronary Artery Bypass Grafting: An Analysis from the National Inpatient Sample Database.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  270. SINGH V, Thakkar B, Rodriguez A, Patel N, et al
    TCT-697 Comparison of Outcomes of Transcatheter Aortic Valve Replacement plus Percutaneous Coronary Intervention versus Transcatheter Aortic Valve Replacement Alone in the United States.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  271. PATEL N, Patel N, Arora S, Singh V, et al
    TCT-680 Impact of Annual Hospital Percutaneous Coronary Intervention Volume on Transcatheter Aortic-Valve Replacement Outcomes.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  272. CHANDRASEKHAR J, Redfors B, Genereux P, Kirtane A, et al
    TCT-65 Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  273. ZBRONSKI K, Huczek Z, Grodecki K, Kochman J, et al
    TCT-651 Impact of preprocedural coronary artery disease assessed by SYNTAX score on TAVI outcome.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  274. VEMULAPALLI S, Lippmann SJ, Krucoff M, Hernandez A, et al
    TCT-645 Cardiovascular Events and Hospital Resource Utilization Pre and Post Transcatheter Mitral Valve Repair in High Surgical Risk Patients.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  275. AZZALINI L, Dautov R, Ojeda S, Bellini B, et al
    TCT-64 Percutaneous coronary intervention for in-stent chronic total occlusion: procedural and long-term outcomes.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  276. ISHIHARA S, Muramatsu T, Kashima Y, Okamura A, et al
    TCT-62 Outcomes of re-attempt percutaneous coronary intervention for chronic total occlusion: 2-year data from Retrograde Summit Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  277. STONE G, Abraham W, Lindenfeld J, Weissman N, et al
    TCT-627 Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients with Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  278. LEE SH, Cho JY, Joo HJ, Park JH, et al
    TCT-620 A comparison of clinical outcomes between triple antithrombotic therapy versus dual antiplatelet with left atrial appendage occlusion in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  279. MASHAYEKHI K, Toma A, Behnes M, Gick M, et al
    TCT-61 Long-term Outcomes of Patients with Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention for Chronic Total Occlusion.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  280. SHAH A, Bach Y, Osten M, Benson L, et al
    TCT-607 Trans-catheter closure of coronary artery fistulae in adult patients & long-term outcomes: A single centre experience.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  281. DRIESEN B, Voskuil M, Sieswerda G, Schoof P, et al
    TCT-606 Can we justify conservative treatment in adults with Anomalous Coronary Artery Originating from the Opposite Sinus of Valsalva (ACAOS) with inter-arterial course (IAC)?
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  282. WEST N, Owen R, Hoole S, Brown A, et al
    TCT-602 Identification of local translesional intracoronary gradients of inflammatory biomolecules during PCI procedures using a novel dedicated sampling catheter.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  283. COSTOPOULOS C, Huang Y, Brown A, Calvert P, et al
    TCT-598 Plaque rupture in coronary atherosclerosis is associated with increased plaque structural stress.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  284. TOBA T, Choi G, Uzu K, Shinke T, et al
    TCT-597 Why does thin-cap fibroatheroma cluster in the proximal segment in left anterior coronary artery, but are evenly distributed throughout the entire right coronary artery? Results from computational fluid dynamics simulation by CT-FFR.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  285. OTA H, Tanigaki T, Okamoto S, Omori H, et al
    TCT-593 The Impact of Coronary Plaque Composition on Fractional Flow Reserve Improvement after Percutaneous Coronary Intervention: An Integrated-backscatter Intravascular Ultrasound Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  286. AGASTHI P, Aloor S, Menon V, Lee K, et al
    TCT-594 Difference in Neointimal Coverage between First Generation versus Second Generation Drug Eluting Stents using Optical Coherence tomography: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  287. SABBAH M, Kadota K, Eraki A, Kamal H, et al
    TCT-596 In-Stent Neoatherosclerosis and Tissue Characteristics of Restenotic Lesions Following Implantation of Second Generation Drug-Eluting Stents in Unrestricted Coronary Lesions: Optical Frequency Domain Imaging study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  288. JINNOUCHI H, Kuramitsu S, Domei T, Ando K, et al
    TCT-592 Difference of Tissue Characteristics between Early and Late Restenosis after Implanting Second-Generation Drug-Eluting Stents Assessed by Optical Coherence Tomography.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  289. TSUKIYAMA Y, Kozuki A, Shinke T, Otake H, et al
    TCT-590 Potent effect of prasugrel on acute phase resolution of intra-stent tissue after percutaneous intervention to acute coronary syndrome.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  290. HASHIMOTO S, Takahashi A, Yamada T, Mizuguchi Y, et al
    TCT-589 Effectiveness of Excimer Laser Coronary Angioplasty with Optical Coherence Tomography Guidance for In-stent Restenosis after Drug Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  291. CAMACHO FREIRE SJ, Menchero AG, Jimenez JL, Piris R, et al
    TCT-586 Utility of intracoronary imaging techniques in the characterisation of substrates causing acute coronary syndrome in normal o near normal coronary angiography (NONCA).
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  292. KIM YH, Rha SW, Her AY, Choi BG, et al
    TCT-584 Is there Benefit in Intravascular Ultrasound-guided Stenting in Simple Left Main Disease?
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  293. VERMA K, Cheshire C, Nerlekar N, McCormick L, et al
    TCT-577 Intravascular ultrasound guidance during percutaneous coronary intervention using second-generation drug-eluting stents improves clinical outcomes and reduces restenosis rates: a comparative 8,265 patient meta-analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  294. ZHANG W, Mintz G, Cao Y, Matsumura M, et al
    TCT-576 Clinical Determinants of Plaque Morphology in Coronary Artery Disease: An OCT and IVUS Co-Registered Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  295. KARACSONYI J, Alaswad K, Jaffer F, Yeh R, et al
    TCT-572 Use of Intravascular Imaging During Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from a Contemporary Multicenter Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  296. REDFORS B, Genereux P, Kirtane A, Pocock S, et al
    TCT-55 Risk-Benefit Analysis of Upstream Antithrombotic Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes Prior to Coronary Angiography.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  297. SONODA S, Sanuki Y, Muraoka Y, Takami H, et al
    TCT-565 Fate of irregular protrusion after second-generation drug-eluting stent implantation: Serial optical coherence tomography study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  298. SHIN DH, Hong SJ, Mintz G, Kim JS, et al
    TCT-564 Effect of Intravascular Ultrasound-Guided vs. Angiography-Guided New-Generation Drug-Eluting Stent Implantation; Meta-analysis with Individual Patient-Level Data from 2,345 Randomized Patients.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  299. SAITO Y, Kitahara H, Nakayama T, Fujimoto Y, et al
    TCT-560 Novel Predictor of Target Vessel Revascularization after Coronary Stent Implantation: Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  300. LEE SH, Cho JY, Joo HJ, Park JH, et al
    TCT-559 Optical coherence tomography (OCT) guided percutaneous coronary intervention : clinical impact of acute abnormal findings after drug-eluting stent implantation detected only by OCT.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  301. SHI B, Liu Z, Deng C, Deng W, et al
    TCT-556 Research and clinical applications of potical coherence tomography in 25 cases of the drug-eluting stents implantated patients with in-stent restenosis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  302. TANG Y, Tian J, Guan C, Wang W, et al
    TCT-555 Intravascular Ultrasound Guidance Improves the Long-term Prognosis in Patients with Unprotected Left Main Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  303. WEBER J, Kassis N, Shah K, Lopez J, et al
    TCT-553 An Optical Coherence Tomography Comparison of Coronary Arterial Plaque Calcification in a Matched Cohort of Patients With and Without End-Stage Renal Disease and Diabetes Mellitus.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  304. ROMAGNOLI E, Gatto L, La Manna A, Burzotta F, et al
    TCT-549 ROLE of RESIDUAL ACUTE STENT MALAPPOSITION in percutaneous coronary interventions: a CLI-OPCI project SUBSTUDY.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  305. DEGRELL P, Adjedj J, Aoumeur H, Navarro A, et al
    TCT-545 Use of optical coherence tomography to detect acute coronary syndrome in survivors of out-of-hospital cardiac arrest without ST-segment elevation on ECG.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  306. ALI Z, Galougahi KK, Nazif T, Maehara A, et al
    TCT-546 Imaging and physiology-guided zero contrast percutaneous coronary intervention in advanced chronic kidney disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  307. PATEL J, Lau E, Kurtz S, Savage M, et al
    TCT-544 Fractional Flow Reserve Utilization in Patients with Stable Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  308. LIOU K, Jepson N, Kushwaha V, Yu J, et al
    TCT-543 Calculation of Serial Index of Microvascular Resistance with Adjusted Wedge Pressure in Patients with Non-ST Elevation Acute Coronary Syndrome.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  309. MATSUSHITA K, Hibi K, Okada K, Matsuzawa Y, et al
    TCT-539 Comparison between Instantaneous Wave-Free Ratio and Fractional Flow Reserve versus Morphometric Assessments by Intracoronary Imaging Devices.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  310. VAN NUNEN L, Hennigan B, Veer MV
    TCT-541 Different performance of iFR in the right and left coronary artery.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  311. GURUNATHAN S, Young G, Karogiannis N, Elghamaz A, et al
    TCT-540 Diagnostic Accuracy of Stress Echocardiography Compared With Invasive Coronary Angiography With Fractional Flow Reserve for the Diagnosis of Haemodynamically Significant Stenosis(Es) in Patients With Known or Suspected Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  312. VAN BOMMEL R, Lemmert M, Wang Y, Daemen J, et al
    TCT-536 Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention with a Novel FFR Micro Catheter, Insights from the FFR-SEARCH Registry - FFR Stent Evaluated at Rotterdam Cardiology Hospital.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  313. ZIMMERMANN F, Pijls N, De Bruyne B, Bech JW, et al
    TCT-537 What can intracoronary pressure measurements tell us about flow reserve? Pressure-bounded CFR and its application to the randomized DEFER trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  314. AHN JM, Cho MS, Kang SH, Park DW, et al
    TCT-534 Fractional Flow Reserve and Cardiac Events In Coronary Artery Disease: Data From Prospective Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  315. AHN JM, Kang SH, Kim TH, Zimmermann F, et al
    TCT-533 Fractional Flow Reserve And Coronary Flow Reserve To Predict Outcomes in Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  316. KOGAME N, Iijima R, Hara H, Anzai H, et al
    TCT-532 Morphometric assessment of hemodynamically severe coronary stenosis relevance with optical frequency domain imaging according to vessel diameter.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  317. RIGATTIERI S, Biondi-Zoccai G, Sciahbasi A, Di RUsso C, et al
    TCT-531 INTRACORONARY VS. INTRAVENOUS ADENOSINE FOR FRACTIONAL FLOW RESERVE MEASUREMENT: A META-ANALYSIS.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  318. CALMAC L, Niculescu R, Badila E, Weiss E, et al
    TCT-527 A data-driven approach combining image-based anatomical features and resting state measurements for the functional assessment of coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  319. DE WAARD G, Nijjer S, van Lavieren M, van der Hoeven N, et al
    TCT-524 Invasive minimal Microvascular Resistance (mMR); a new index to assess microcirculatory dysfunction that is not modulated by the presence of angiographic coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  320. KOBAYASHI Y, Lee JM, Fearon W, Lee J, et al
    TCT-522 The Independence of Coronary Microvascular Dysfunction from Epicardial Disease Severity: Three-Vessel Invasive Coronary Physiologic Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  321. SAINSOUS J, Fajadet J, Carrie D, Elhadad S, et al
    TCT-51 In hospital and one month outcomes of 983 patients implanted with bioresorbable vascular scaffolds for Acute Coronary Syndroms; subgroup of the prospective, all comers, controlled, multicenter, FRANCE ABSORB Registry.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  322. KUBO S, Kuwayama A, Shimada T, Miura K, et al
    TCT-52 Proportion and Morphological Features of Restenosis Lesions with Acute Coronary Syndrome in Different Timings of Target Lesion Revascularization after Sirolimus-Eluting Stent Implantation.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  323. PESARINI G, Scarsini R, Zivelonghi C, Piccoli A, et al
    TCT-517 Fractional flow reserve assessment of coronary artery disease in patients Undergoing TAVI.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  324. OKURA H, Kobayashi Y, Neishi Y, Higa T, et al
    TCT-518 The Interaction between Aortic and Coronary Pressures for Fractional Flow Reserve Value in Patients with an Intermediate Coronary Artery Stenosis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  325. KIM HY, Doh JH, Lim HS, Yoon MH, et al
    TCT-514 Comparison of angiographic scores and fractional myocardial mass: Use of fractional myocardial mass for comprehensive evaluation of coronary artery disease.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  326. KWON SU
    TCT-508 The PREDICT (Prognostic Role of coronary artery plaquEs in patients with suspected coronary artery Disease using multislice Computed Tomography) observational comparative outcomes study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  327. WOLNY R, Pregowski J, Kruk M, Kepka C, et al
    TCT-507 Computed Tomography Angiography Versus Angiography for Guiding Percutaneous Coronary Interventions in Bifurcation Lesions - Prospective Randomized Pilot Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  328. OTAGIRI K, Yui H, Nakamura C, Sakai T, et al
    TCT-503 Impact of Visceral Fat Accumulation on Coronary Artery Disease Severity Stratified by Computed Tomography-derived SYNTAX Score.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  329. AGASTHI P, Kanmanthareddy A, Egbuche O, Yarlagadda V, et al
    TCT-504 Comparison of Computed Tomography derived Fractional Flow Reserve to invasive Fractional Flow Reserve in Diagnosis of Functional Coronary Stenosis: A Meta-Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  330. PLEWKA M, Peruga J, Peruga J, Tondo C, et al
    TCT-501 Ultrasound examination of the forearm arteries morphology and anomalies in patients undergoing percutaneous coronary intervention via radial access.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  331. PARK DW, Kang SH, Park SJ, Lee PH, et al
    TCT-47 Secular Trends in Characteristics, Treatments, and Outcomes in Patients with Unprotected Left Main Coronary Artery Disease Over Two Decades.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  332. ENG LK, Starovoytov A, Humphries K, Mancini GB, et al
    TCT-48 Medical Therapy and Clinical Outcomes with Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  333. EBRAHIMI R, Mehran R, Ben-Yehuda O, Parvataneni R, et al
    TCT-5 Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights from the ACUITY trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  334. THEODOROPOULOS K, Meelu O, Mennuni M, Sartori S, et al
    TCT-496 Differences in quantitative coronary angiographic (QCA) characteristics of coronary artery disease between Human Immunodeficiency Virus (HIV) patients presenting with acute coronary syndrome (ACS) and stable angina pectoris (SAP) undergoing pe
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  335. KANG JH, Rha SW, Choi BG, Byun JK, et al
    TCT-497 A Novel Scoring System Predicting Major Adverse Cardiac Events in Coronary Artery Spasm Patients: A Large-scale Simulation Analysis.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  336. HERNANDEZ E, Diaz VJ, Juan-Salvadores P, Vitela J, et al
    TCT-491 Comparative analysis of the right radial vascular access vs. left at more than 10,000 diagnostic coronary angiography.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  337. KIM WH, Rha SW, Choi BG, Byun JK, et al
    TCT-489 Impact of Left Ventricular Hypertrophy on Coronary Artery Spasm as assessed by Acetylcholine Provocation Test.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  338. KIM YH, Rha SW, Her AY, Choi BG, et al
    TCT-490 Five-year Clinical Outcomes Are Different according to the Severity of Coronary Artery Spasm as Assessed by Intracoronary Acetylcholine Provocation Test.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  339. MAJUMDAR S, Krishnan H, Kumar A
    TCT-488 Congenital Coronary Anomalies of Origin and Distribution in Adult Patients referred for Coronary angiography.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  340. HARADA Y, Colleran R, Kufner S, Giacoppo D, et al
    TCT-483 Angiographic and two-year clinical outcomes following percutaneous coronary intervention for in-stent restenosis of polymer-free sirolimus- and probucol-eluting stent compared with durable polymer zotarolimus-eluting stent.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  341. DURGAPRASAD R, Vanajakshamma V, Vamsidhar A, Kasala L, et al
    TCT-485 A study of safety and efficacy of biodegradable polymer coated Everolimus-eluting coronary stent system [Everoflex] at intermediate follow-up in real world scenario.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  342. VOLZ S, Dworeck C, Angeras O, Haraldsson I, et al
    TCT-482 First generation drug-eluting stent is worse than contemporary bare metal stent after long-term follow-up: A report from SCAAR.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  343. GIL R, Bil J, Vassilev D, Kern A, et al
    TCT-480 Regular drug eluting stents versus dedicated bifurcation drug eluting BiOSS(R) stents in coronary bifurcation treatment - outcome predicting factors and long-term results of two international, multicenter, randomized POLBOS I and POLBOS II cli
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  344. PANCHAL H, Bhattad V, Murtaza G, Vladimirov G, et al
    TCT-479 Mortality and Major Adverse Cardiovascular Events of Polymer Free Drug Coated Stents versus Polymer Based Drug Eluting Stents: A Meta-Analysis of Randomized Controlled Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  345. DWORECK C, Angeras O, Haraldsson I, Ioanes D, et al
    TCT-477 Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  346. GIUSTINO G, Melegari C, Baber U, Sartori S, et al
    TCT-475 Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  347. HAN Y, Yang Y, Fu G, Su XI, et al
    TCT-473 A Randomized Comparison of Biodegradable Polymer- and Permanent Polymer-coated Platinum Chromium Everolimus-Eluting Coronary Stents in China: EVOLVE China Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  348. CAMACHO FREIRE SJ, Menchero AG, Jimenez JL, Tawfik H, et al
    TCT-46 Coronary artery aneurysms: incididence, etiology, management and outcomes in a long-term follow up.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  349. VASSILEV D, Karamfiloff K, Dosev L, Stoykova J, et al
    TCT-45 Five Year Mortality Predictors After provisional T-stenting in Coronary Bifurcation Lesions, with Intracoronary Electrocardiogram Change Defined Strategy. From Intracoronary Electrocardiogram (ECG) and Myonecrosis After Bifurcation Stenting (CO
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  350. VOGEL B, Baber U, Giustino G, Sartori S, et al
    TCT-471 Impact of New- versus Early-Generation Drug Eluting Stents in Women according to Age: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  351. VERHEYE S, Abizaid A, Botelho R, Costa R, et al
    TCT-460 Multi-Center, Randomized Evaluation of the Elixir DESyne(R) Novolimus Eluting Coronary Stent System with Biodegradable Polymer Compared to a Zotarolimus-Eluting Coronary Stent System: Final 5-Year Results from the EXCELLA BD Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  352. KAUL U, Abhaichand DR, Patel T, Banker D, et al
    TCT-457 Paclitaxel - eluting stents vs Everolimus - eluting Coronary Stents in a Diabetic population: 2 Years Follow-up of TUXEDO-India Trial.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  353. VERHEYE S, Stella P, Carrie D, Khattab A, et al
    TCT-456 Direct Implantation of Rapamycin-Eluting Stents with Bioresorbable Drug Carrier Technology Utilizing the Svelte Coronary Stent-on-a-Wire: 2-Year Follow-Up of the Randomized, Controlled DIRECT II Study.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  354. GIUSTINO G, Baber U, Sartori S, Stone G, et al
    TCT-453 Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  355. TOKLU B, Bangalore S, Kaul U, Attubato M, et al
    TCT-450 Bare Metal Stent, Durable Polymer Drug Eluting Stent, or Biodegradable Polymer Drug Eluting Stent in Patients with Diabetes Mellitus - A Mixed Treatment Comparison Analysis of 63,940 Patient-Years of Follow-up from Randomized Trials.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  356. SLAGBOOM T, Haude M, Lefevre T, Hayek S, et al
    TCT-448 BIOTRONIK-Safety and Clinical Performance of the Drug Eluting Orsiro Stent in the Treatment of Subjects With Single De Novo Coronary Artery Lesions-II (BIOFLOW-II) - 4 Year Clinical Results.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  357. TORII S, Kolodgie F, Cheng D, Acampado E, et al
    TCT-446 Fluoropassivation of Coronary Stents as a Potential Mechanism of Improved Thromboresistance.
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


  358. LEE SY, Torguson R, Garcia-Garcia HM, Tang G, et al
    TCT-445 Does the Risk of Bleeding Impacts Selection of Stent Type during Percutaneous Coronary Intervention?
    J Am Coll Cardiol. 2016;68.
    PubMed     Text format    


    October 2016
  359. LLOYD-JONES DM, Huffman MD, Karmali KN, Sanghavi DM, et al
    Estimating Longitudinal Risks and Benefits From Cardiovascular Preventive Therapies Among Medicare Patients: The Million Hearts Longitudinal ASCVD Risk Assessment Tool.
    J Am Coll Cardiol. 2016 Oct 28. pii: S0735-1097(16)36692.
    PubMed     Text format     Abstract available


  360. OUWENEEL DM, Eriksen E, Sjauw KD, van Dongen IM, et al
    Impella CP Versus Intra-Aortic Balloon Pump in Acute Myocardial Infarction Complicated by Cardiogenic Shock: The IMPRESS trial.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36767.
    PubMed     Text format     Abstract available


  361. KINI AS, Vengrenyuk Y, Shameer K, Maehara A, et al
    Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes after Intensive Statin Treatment: The YELLOW II study.
    J Am Coll Cardiol. 2016 Oct 27. pii: S0735-1097(16)36776.
    PubMed     Text format     Abstract available


  362. JONES WS, Roe MT, Antman EM, Pletcher MJ, et al
    The Changing Landscape of Randomized Clinical Trials in Cardiovascular Disease.
    J Am Coll Cardiol. 2016;68:1898-1907.
    PubMed     Text format     Abstract available


  363. WELSH RC, Peterson ED
    Selecting the Duration of Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Complex Decision or Not?
    J Am Coll Cardiol. 2016;68:1865-1867.
    PubMed     Text format    


  364. MECHANICK JI, Zhao S, Garvey WT
    The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice.
    J Am Coll Cardiol. 2016;68:1785-1803.
    PubMed     Text format     Abstract available


  365. NARANG A, Sinha SS, Rajagopalan B, Ijioma NN, et al
    The Supply and Demand of the Cardiovascular Workforce: Striking the Right Balance.
    J Am Coll Cardiol. 2016;68:1680-1689.
    PubMed     Text format     Abstract available


  366. RAPHAEL CE, Cooper R, Parker KH, Collinson J, et al
    Mechanisms of Myocardial Ischemia in Hypertrophic Cardiomyopathy: Insights From Wave Intensity Analysis and Magnetic Resonance.
    J Am Coll Cardiol. 2016;68:1651-1660.
    PubMed     Text format     Abstract available


  367. BRILAKIS ES, Abdullah SM, Banerjee S
    Who Should Undergo Chronic Total Occlusion Percutaneous Coronary Intervention?: The EXPLORation Continues.
    J Am Coll Cardiol. 2016;68:1633-1636.
    PubMed     Text format    


  368. GUPTA SK, Foinquinos A, Thum S, Remke J, et al
    Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:1557-71.
    PubMed     Text format     Abstract available


  369. NEELAND IJ, de Lemos JA
    Time to Retire the BMI?: Evaluating Abdominal Adipose Tissue Imaging as Novel Cardiovascular Risk Biomarker.
    J Am Coll Cardiol. 2016;68:1522-4.
    PubMed     Text format    


  370. LEE JJ, Pedley A, Hoffmann U, Massaro JM, et al
    Association of Changes in Abdominal Fat Quantity and Quality With Incident Cardiovascular Disease Risk Factors.
    J Am Coll Cardiol. 2016;68:1509-21.
    PubMed     Text format     Abstract available


    September 2016
  371. GOSMANOVA EO, Mikkelsen MK, Molnar MZ, Lu JL, et al
    Association of Systolic Blood Pressure Variability With Mortality, Coronary Heart Disease, Stroke, and Renal Disease.
    J Am Coll Cardiol. 2016;68:1375-86.
    PubMed     Text format     Abstract available


  372. PILOTE L
    Reply: Sex Versus Gender in Recurrent Events Following Acute Coronary Syndrome: A "Femininity Paradox?".
    J Am Coll Cardiol. 2016;68:1372.
    PubMed     Text format    


  373. PAULUS JK, Kent DM
    Sex Versus Gender in Recurrent Events Following Acute Coronary Syndrome: A "Femininity Paradox?".
    J Am Coll Cardiol. 2016;68:1371-2.
    PubMed     Text format    


  374. KUVIN JT, Williams ES
    Defining, Achieving, and Maintaining Competence in Cardiovascular Training and Practice.
    J Am Coll Cardiol. 2016;68:1342-7.
    PubMed     Text format     Abstract available


  375. FAN Y, Li Y, Chen Y, Zhao YJ, et al
    Comprehensive Metabolomic Characterization of Coronary Artery Diseases.
    J Am Coll Cardiol. 2016;68:1281-93.
    PubMed     Text format     Abstract available


  376. ACKERMAN MJ, Giudicessi JR
    Post-Mortem Cardiovascular Implantable Electronic Device Interrogation: Clinical Indications and Potential Benefits.
    J Am Coll Cardiol. 2016;68:1265-7.
    PubMed     Text format    


  377. SINHA SK, Crain B, Flickinger K, Calkins H, et al
    Clinical Inferences of Cardiovascular Implantable Electronic Device Analysis at Autopsy.
    J Am Coll Cardiol. 2016;68:1255-64.
    PubMed     Text format     Abstract available


  378. VAUSORT M, Salgado-Somoza A, Zhang L, Leszek P, et al
    Myocardial Infarction-Associated Circular RNA Predicting Left Ventricular Dysfunction.
    J Am Coll Cardiol. 2016;68:1247-8.
    PubMed     Text format    


  379. ALEXOPOULOS D, Xanthopoulou I, Moulias A, Lekakis J, et al
    Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients: Facing a New Trilemma?
    J Am Coll Cardiol. 2016;68:1223-32.
    PubMed     Text format     Abstract available


  380. LEE PH, Ahn JM, Chang M, Baek S, et al
    Left Main Coronary Artery Disease: Secular Trends in Patient Characteristics, Treatments, and Outcomes.
    J Am Coll Cardiol. 2016;68:1233-46.
    PubMed     Text format     Abstract available


  381. FEARON WF, De Bruyne B, Pijls NH
    Fractional Flow Reserve in Acute Coronary Syndromes.
    J Am Coll Cardiol. 2016;68:1192-4.
    PubMed     Text format    


  382. HAKEEM A, Edupuganti MM, Almomani A, Pothineni NV, et al
    Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve.
    J Am Coll Cardiol. 2016;68:1181-91.
    PubMed     Text format     Abstract available


  383. BATES ER, Tamis-Holland JE, Bittl JA, O'Gara PT, et al
    PCI Strategies in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
    J Am Coll Cardiol. 2016;68:1066-81.
    PubMed     Text format     Abstract available


  384. MANCINI GB, Farkouh ME, Brooks MM, Chaitman BR, et al
    Medical Treatment and Revascularization Options in Patients With Type 2 Diabetes and Coronary Disease.
    J Am Coll Cardiol. 2016;68:985-95.
    PubMed     Text format     Abstract available


  385. WINDECKER S, Piccolo R
    Myocardial Revascularization for Left Main Coronary Artery Disease: A Step Toward Individualized Treatment Selection.
    J Am Coll Cardiol. 2016;68:1010-3.
    PubMed     Text format    


  386. CAVALCANTE R, Sotomi Y, Lee CW, Ahn JM, et al
    Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease.
    J Am Coll Cardiol. 2016;68:999-1009.
    PubMed     Text format     Abstract available


    August 2016
  387. EVERETT BM, Brooks MM, Vlachos HE, Chaitman BR, et al
    Sex Differences in Cardiac Troponin and the Risk of Death or Major Cardiovascular Events.
    J Am Coll Cardiol. 2016;68:978-80.
    PubMed     Text format    


  388. LEVIN A, Lan JH
    Cystatin C and Cardiovascular Disease: Causality, Association, and Clinical Implications of Knowing the Difference.
    J Am Coll Cardiol. 2016;68:946-8.
    PubMed     Text format    


  389. VAN DER LAAN SW, Fall T, Soumare A, Teumer A, et al
    Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study.
    J Am Coll Cardiol. 2016;68:934-45.
    PubMed     Text format     Abstract available


  390. SUTTON NR, Seth M, Ruwende C, Gurm HS, et al
    Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:895-904.
    PubMed     Text format     Abstract available


  391. SELVARAJ S, Bhatt DL, Stone GW, Gibson CM, et al
    "Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX.
    J Am Coll Cardiol. 2016 Aug 25. pii: S0735-1097(16)35036.
    PubMed     Text format    


  392. ATKINS JL, Pilling LC, Ble A, Dutta A, et al
    Longer-Lived Parents and Cardiovascular Outcomes: 8-Year Follow-Up In 186,000 U.K. Biobank Participants.
    J Am Coll Cardiol. 2016;68:874-5.
    PubMed     Text format    


  393. LABARTHE DR, Kubzansky LD, Boehm JK, Lloyd-Jones DM, et al
    Positive Cardiovascular Health: A Timely Convergence.
    J Am Coll Cardiol. 2016;68:860-7.
    PubMed     Text format     Abstract available


  394. VORSANGER MH, Subramanyam P, Weintraub HS, Lamm SH, et al
    Cardiovascular Effects of the New Weight Loss Agents.
    J Am Coll Cardiol. 2016;68:849-59.
    PubMed     Text format     Abstract available


  395. BLOOMFIELD GS, Leung Yinko SS
    A Series of Unhealthy Developments: The Multiple Facets of Cardiovascular Risk Factors in China.
    J Am Coll Cardiol. 2016;68:834-5.
    PubMed     Text format    


  396. LI Y, Wang DD, Ley SH, Howard AG, et al
    Potential Impact of Time Trend of Life-Style Factors on Cardiovascular Disease Burden in China.
    J Am Coll Cardiol. 2016;68:818-33.
    PubMed     Text format     Abstract available


  397. BANSILAL S, Castellano JM, Garrido E, Wei HG, et al
    Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes.
    J Am Coll Cardiol. 2016;68:789-801.
    PubMed     Text format     Abstract available


  398. RAO SV, Zeymer U, Douglas PS, Al-Khalidi H, et al
    Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:715-23.
    PubMed     Text format     Abstract available


  399. CALIFF RM
    The Future of Cardiovascular Medicine From the Regulatory Perspective.
    J Am Coll Cardiol. 2016;68:766-9.
    PubMed     Text format    


  400. HENRIQUES JP, Kikkert WJ
    Intracoronary Abciximab in Diabetic STEMI Patients: Questionable Benefit, Proven Harm.
    J Am Coll Cardiol. 2016;68:739-41.
    PubMed     Text format    


  401. PICCOLO R, Eitel I, Galasso G, Dominguez-Rodriguez A, et al
    1-Year Outcomes With Intracoronary Abciximab in Diabetic Patients Undergoing Primary Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:727-38.
    PubMed     Text format     Abstract available


  402. SOLOMON MD, Leong TK, Rana JS, Xu Y, et al
    Community-Based Trends in Acute Myocardial Infarction From 2008 to 2014.
    J Am Coll Cardiol. 2016;68:666-8.
    PubMed     Text format    


  403. WILSON PW, D'Agostino RB Sr
    No One Size Fits All: Scoring Risk of In-Hospital Death After Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:636-8.
    PubMed     Text format    


  404. MCNAMARA RL, Kennedy KF, Cohen DJ, Diercks DB, et al
    Predicting In-Hospital Mortality in Patients With Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:626-35.
    PubMed     Text format     Abstract available


  405. GAUDINO M, Tondi P, Benedetto U, Milazzo V, et al
    Radial Artery as a Coronary Artery Bypass Conduit: 20-Year Results.
    J Am Coll Cardiol. 2016;68:603-10.
    PubMed     Text format     Abstract available


  406. RIBEIRO HB, Orwat S, Hayek SS, Larose E, et al
    Cardiovascular Magnetic Resonance to Evaluate Aortic Regurgitation After Transcatheter Aortic Valve Replacement.
    J Am Coll Cardiol. 2016;68:577-85.
    PubMed     Text format     Abstract available


  407. YOUNG JB, Stehlik J
    Ischemic Heart Disease in New-Onset Heart Failure, or Finding Waldo: Where's Waldo?
    J Am Coll Cardiol. 2016;68:459-60.
    PubMed     Text format    


  408. DOUGLAS PS, De Bruyne B, Pontone G, Patel MR, et al
    1-Year Outcomes of FFRCT-Guided Care in Patients With Suspected Coronary Disease: The PLATFORM Study.
    J Am Coll Cardiol. 2016;68:435-45.
    PubMed     Text format     Abstract available


  409. ELGENDY IY, Mahmoud AN, Elgendy AY, Bavry AA, et al
    Does the Baseline Coronary Lesion Length Impact Outcomes With IVUS-Guided Percutaneous Coronary Intervention?
    J Am Coll Cardiol. 2016;68:569-70.
    PubMed     Text format    


  410. DOSHI D, Ben-Yehuda O, Bonafede M, Josephy N, et al
    Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.
    J Am Coll Cardiol. 2016;68:450-8.
    PubMed     Text format     Abstract available


    July 2016
  411. HAWRANEK M, Wrobel M, Nozynski J, Pres D, et al
    Hemorrhagic Myocardial Infarction: Mortality Compared With STEMI Patients Treated With Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;68:426-7.
    PubMed     Text format    


  412. DAUERMAN HL
    The Expanding Universe of Perioperative Myocardial Infarction.
    J Am Coll Cardiol. 2016;68:339-42.
    PubMed     Text format    


  413. PARASHAR A, Agarwal S, Krishnaswamy A, Sud K, et al
    Percutaneous Intervention for Myocardial Infarction After Noncardiac Surgery: Patient Characteristics and Outcomes.
    J Am Coll Cardiol. 2016;68:329-38.
    PubMed     Text format     Abstract available


  414. KHAN A, Gilani S, Dharmashankar K, Jaffery Z, et al
    Percutaneous Coronary Intervention After Transcatheter Aortic Valve Replacement: Approach and Challenges.
    J Am Coll Cardiol. 2016;68:432-3.
    PubMed     Text format    


  415. DIEGELER A
    Hybrid Coronary Revascularization: The Best of 2 Worlds?
    J Am Coll Cardiol. 2016;68:366-7.
    PubMed     Text format    


  416. PUSKAS JD, Halkos ME, DeRose JJ, Bagiella E, et al
    Hybrid Coronary Revascularization for the Treatment of Multivessel Coronary Artery Disease: A Multicenter Observational Study.
    J Am Coll Cardiol. 2016;68:356-65.
    PubMed     Text format     Abstract available


  417. BONACA MP, O'Malley RG, Jarolim P, Scirica BM, et al
    Serial Cardiac Troponin Measured Using a High-Sensitivity Assay in Stable Patients With Ischemic Heart Disease.
    J Am Coll Cardiol. 2016;68:322-3.
    PubMed     Text format    


  418. HASIN T, Gerber Y, Weston SA, Jiang R, et al
    Heart Failure After Myocardial Infarction Is Associated With Increased Risk of Cancer.
    J Am Coll Cardiol. 2016;68:265-71.
    PubMed     Text format     Abstract available


  419. SAW J, Mancini GB, Humphries KH
    Contemporary Review on Spontaneous Coronary Artery Dissection.
    J Am Coll Cardiol. 2016;68:297-312.
    PubMed     Text format     Abstract available


  420. BESSELING J, Hovingh GK, Huijgen R, Kastelein JJ, et al
    Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
    J Am Coll Cardiol. 2016;68:252-60.
    PubMed     Text format     Abstract available


  421. MANGIACAPRA F, Di Gioia G, Pellicano M, Di Serafino L, et al
    Effects of Prasugrel Versus Clopidogrel on Coronary Microvascular Function in Patients Undergoing Elective PCI.
    J Am Coll Cardiol. 2016;68:235-7.
    PubMed     Text format    


  422. SIASOS G, Stefanadis C, Tousoulis D
    Factors Affecting Platelet Reactivity and Cardiovascular Outcome in CAD Patients Treated With P2Y12 Receptor Inhibitors.
    J Am Coll Cardiol. 2016;68:134.
    PubMed     Text format    


  423. SELVARAJ S, Steg PG, Elbez Y, Sorbets E, et al
    Reply: Pulse Pressure and Cardiovascular Death.
    J Am Coll Cardiol. 2016;68:132-3.
    PubMed     Text format    


  424. AZNAOURIDIS K, Vlachopoulos C, Tousoulis D
    Pulse Pressure and Cardiovascular Death.
    J Am Coll Cardiol. 2016;68:131-2.
    PubMed     Text format    


  425. CHANG M, Ahn JM, Lee CW, Cavalcante R, et al
    Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease.
    J Am Coll Cardiol. 2016;68:29-36.
    PubMed     Text format     Abstract available


    June 2016
  426. MURPHY SA, Cannon CP, Blazing MA, Giugliano RP, et al
    Reply: Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
    J Am Coll Cardiol. 2016;67:3025-6.
    PubMed     Text format    


  427. MASCITELLI L, Goldstein MR
    Adding Ezetimibe to Simvastatin for the Secondary Prevention of Cardiovascular Disease: Is it Useful?
    J Am Coll Cardiol. 2016;67:3025.
    PubMed     Text format    


  428. SEALS AA
    ACC International Outreach and the Global Cardiovascular Community.
    J Am Coll Cardiol. 2016;67:3011-3.
    PubMed     Text format    


  429. WEINRAUCH LA, Segal AR, D'Elia JA
    Cardiovascular Risk Reduction and the Community Pharmacist.
    J Am Coll Cardiol. 2016;67:2855-7.
    PubMed     Text format    


  430. KO MJ, Jo AJ, Park CM, Kim HJ, et al
    Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    J Am Coll Cardiol. 2016;67:2821-31.
    PubMed     Text format     Abstract available


  431. HIATT WR, Rogers RK
    The Development of Therapeutics for Peripheral Artery Disease: A Unique Cardiovascular Risk Population.
    J Am Coll Cardiol. 2016;67:2729-31.
    PubMed     Text format    


  432. SCHMID-SCHONBEIN GW
    Can Fishy Odor Be a Risk Factor for Coronary Artery Disease?
    J Am Coll Cardiol. 2016;67:2629-30.
    PubMed     Text format    


  433. GIDDING SS
    Familial Hypercholesterolemia: Now Part of Cardiovascular Disease Genetic Epidemiology Research.
    J Am Coll Cardiol. 2016;67:2590-2.
    PubMed     Text format    


    May 2016
  434. ANTIOCHOS P, Marques-Vidal P, Vollenweider P
    Genetic Scores and Prediction of Atherosclerotic Cardiovascular Disease: Moving From Short-Term to Lifetime Risk Assessment.
    J Am Coll Cardiol. 2016;67:2558-9.
    PubMed     Text format    


  435. MAHMUD E, Behnamfar O, Lin F, Reeves R, et al
    Elevated Serum Fibrinogen Is Associated With 12-Month Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention.
    J Am Coll Cardiol. 2016;67:2556-7.
    PubMed     Text format    


  436. STONE GW
    DAPT Duration After Coronary Stenting: Assessing Risk-Benefit Tradeoffs in Individual Patients.
    J Am Coll Cardiol. 2016;67:2503-5.
    PubMed     Text format    


  437. MODY P, Joshi PH, Khera A, Ayers CR, et al
    Beyond Coronary Calcification, Family History, and C-Reactive Protein: Cholesterol Efflux Capacity and Cardiovascular Risk Prediction.
    J Am Coll Cardiol. 2016;67:2480-7.
    PubMed     Text format     Abstract available


  438. LAMAS GA, Navas-Acien A, Mark DB, Lee KL, et al
    Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.
    J Am Coll Cardiol. 2016;67:2411-8.
    PubMed     Text format     Abstract available


  439. MENTZ RJ, Newby LK, Neely B, Lucas JE, et al
    Assessment of Administrative Data to Identify Acute Myocardial Infarction in Electronic Health Records.
    J Am Coll Cardiol. 2016;67:2441-2.
    PubMed     Text format    


  440. BUCHOLZ EM, Butala NM, Normand SL, Wang Y, et al
    Association of Guideline-Based Admission Treatments and Life Expectancy After Myocardial Infarction in Elderly Medicare Beneficiaries.
    J Am Coll Cardiol. 2016;67:2378-91.
    PubMed     Text format     Abstract available


  441. SINNECKER D, Dommasch M, Steger A, Berkefeld A, et al
    Expiration-Triggered Sinus Arrhythmia Predicts Outcome in Survivors of Acute Myocardial Infarction.
    J Am Coll Cardiol. 2016;67:2213-20.
    PubMed     Text format     Abstract available


  442. MINER SE, Nield LE
    Obesity Cardiovascular Disease and the Failure of Public Health Education.
    J Am Coll Cardiol. 2016;67:2315-6.
    PubMed     Text format    


  443. FABRIS F, Rice TK, Jeffe DB, Czajkowski SM, et al
    Junior Faculty Career Development Through an NHLBI Program to Increase Diversity in Cardiovascular Health-Related Research.
    J Am Coll Cardiol. 2016;67:2312-3.
    PubMed     Text format    


  444. BROWNELL NK, Khera A, de Lemos JA, Ayers CR, et al
    Association Between Peptidoglycan Recognition Protein-1 and Incident Atherosclerotic Cardiovascular Disease Events: The Dallas Heart Study.
    J Am Coll Cardiol. 2016;67:2310-2.
    PubMed     Text format    


  445. WENGER NK, Ouyang P, Miller VM, Bairey Merz CN, et al
    Strategies and Methods for Clinical Scientists to Study Sex-Specific Cardiovascular Health and Disease in Women.
    J Am Coll Cardiol. 2016;67:2186-8.
    PubMed     Text format    


  446. VRANCKX P, White HD, Huang Z, Mahaffey KW, et al
    Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial.
    J Am Coll Cardiol. 2016;67:2135-44.
    PubMed     Text format     Abstract available


  447. RANA JS, Tabada GH, Solomon MD, Lo JC, et al
    Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population.
    J Am Coll Cardiol. 2016;67:2118-30.
    PubMed     Text format     Abstract available


    April 2016
  448. PITT B
    MRAs in Patients With AMI Without Early Evidence of Heart Failure: Time for Reappraisal?
    J Am Coll Cardiol. 2016;67:1928-30.
    PubMed     Text format    


  449. ZEB I, Li D, Budoff MJ, Katz R, et al
    Nonalcoholic Fatty Liver Disease and Incident Cardiac Events: The Multi-Ethnic Study of Atherosclerosis.
    J Am Coll Cardiol. 2016;67:1965-6.
    PubMed     Text format    


  450. TORNVALL P, Collste O, Ehrenborg E, Jarnbert-Petterson H, et al
    A Case-Control Study of Risk Markers and Mortality in Takotsubo Stress Cardiomyopathy.
    J Am Coll Cardiol. 2016;67:1931-6.
    PubMed     Text format     Abstract available


  451. FERNANDEZ-JIMENEZ R, Fuster V, Ibanez B
    Reply: "Waves of Edema" Seem Implausible.
    J Am Coll Cardiol. 2016;67:1869-70.
    PubMed     Text format    


  452. BERRY C, Carrick D, Haig C, Oldroyd KG, et al
    "Waves of Edema" Seem Implausible.
    J Am Coll Cardiol. 2016;67:1868-9.
    PubMed     Text format    


  453. ISHII M, Kaikita K, Ogawa H
    Reply: Could Plaque Composition-Related Endothelial Dysfunction Predict Poor Prognosis in Coronary Vasospastic Angina?
    J Am Coll Cardiol. 2016;67:1867-8.
    PubMed     Text format    


  454. ORTEGA-PAZ L, Garcia-Garcia HM, Brugaletta S
    Could Plaque Composition-Related Endothelial Dysfunction Predict Poor Prognosis in Coronary Vasospastic Angina?
    J Am Coll Cardiol. 2016;67:1867.
    PubMed     Text format    


  455. NISSEN SE
    IVUS Virtual Histology: Unvalidated Gimmick or Useful Technique?
    J Am Coll Cardiol. 2016;67:1784-5.
    PubMed     Text format    


  456. PARK SJ, Kang SJ, Ahn JM, Chang M, et al
    Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.
    J Am Coll Cardiol. 2016;67:1772-83.
    PubMed     Text format     Abstract available


  457. MIN JK, Jones EC, Pena JM
    The Future From the Past: A Chance for Change.
    J Am Coll Cardiol. 2016;67:1769-71.
    PubMed     Text format    


  458. VERMOND RA, Geelhoed B, Rienstra M
    Reply: Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not To Be Disregarded.
    J Am Coll Cardiol. 2016;67:1754-5.
    PubMed     Text format    


  459. ONAT A, Simsek B, Akbas T
    Antihypertensive Drug Usage in Prediction of Incident Atrial Fibrillation: A Factor Not to Be Disregarded.
    J Am Coll Cardiol. 2016;67:1753-4.
    PubMed     Text format    


  460. NEWBURGER JW, Takahashi M, Burns JC
    Kawasaki Disease.
    J Am Coll Cardiol. 2016;67:1738-49.
    PubMed     Text format     Abstract available


  461. NAPPI AG, Boden WE
    Does Physiology Trump Anatomy as the "Best Course" to Guide PCI Decision Making and Outcomes?
    J Am Coll Cardiol. 2016;67:1712-4.
    PubMed     Text format    


  462. GIBBONS RJ, Araoz P
    Does Infarct Size Matter?
    J Am Coll Cardiol. 2016;67:1684-6.
    PubMed     Text format    


  463. STONE GW, Selker HP, Thiele H, Patel MR, et al
    Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis From 10 Randomized Trials.
    J Am Coll Cardiol. 2016;67:1674-83.
    PubMed     Text format     Abstract available


  464. VADUGANATHAN M, Bhatt DL, Cryer BL, Liu Y, et al
    Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2016;67:1661-71.
    PubMed     Text format     Abstract available


  465. FUSTER V
    What Makes General Cardiovascular Education Courses Successful?
    J Am Coll Cardiol. 2016;67:1651-2.
    PubMed     Text format    


  466. KARIO K, Saito I, Kushiro T, Teramukai S, et al
    Morning Home Blood Pressure Is a Strong Predictor of Coronary Artery Disease: The HONEST Study.
    J Am Coll Cardiol. 2016;67:1519-27.
    PubMed     Text format     Abstract available


  467. SMITH SC JR
    Adherence to Medical Therapy and the Global Burden of Cardiovascular Disease.
    J Am Coll Cardiol. 2016;67:1516-8.
    PubMed     Text format    


    March 2016
  468. TRANBAUGH RF, Schwann TA, Habib RH
    Reply: CABG Versus PCI: Are All Revascularization Strategies Created Equal?
    J Am Coll Cardiol. 2016;67:1504-5.
    PubMed     Text format    


  469. PHILIP F, Southard JA
    CABG Versus PCI: Are All Revascularization Strategies Created Equal?
    J Am Coll Cardiol. 2016;67:1503-4.
    PubMed     Text format    


  470. HENDERSON RA, Jarvis C, Clayton T, Pocock SJ, et al
    Reply: Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?
    J Am Coll Cardiol. 2016;67:1502-3.
    PubMed     Text format    


  471. MCDANIEL M, Wenger N
    Do the 10-Year Mortality Outcomes of RITA-3 Inform Contemporary Clinical Practice?
    J Am Coll Cardiol. 2016;67:1502.
    PubMed     Text format    


  472. CHANG TI, Montez-Rath ME, Tsai TT, Hlatky MA, et al
    Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis.
    J Am Coll Cardiol. 2016;67:1459-69.
    PubMed     Text format     Abstract available


  473. LACLAUSTRA M, Casasnovas JA, Fernandez-Ortiz A, Fuster V, et al
    Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study.
    J Am Coll Cardiol. 2016;67:1263-74.
    PubMed     Text format     Abstract available


  474. BOON RA, Jae N, Holdt L, Dimmeler S, et al
    Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets?
    J Am Coll Cardiol. 2016;67:1214-26.
    PubMed     Text format     Abstract available


  475. BRAR SS
    The Yin and Yang of Long-Term Dual Antiplatelet Therapy.
    J Am Coll Cardiol. 2016;67:1155-7.
    PubMed     Text format    


  476. STOREY RF, Angiolillo DJ, Bonaca MP, Thomas MR, et al
    Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial.
    J Am Coll Cardiol. 2016;67:1145-54.
    PubMed     Text format     Abstract available


  477. WALLER C, Bauersachs J, Hoppmann U, Hoch J, et al
    Blunted Cortisol Stress Response and Depression-Induced Hypocortisolism Is Related to Inflammation in Patients With CAD.
    J Am Coll Cardiol. 2016;67:1124-6.
    PubMed     Text format    


  478. COSTA KD
    Decellularized Scaffold Hydrogel Materials for MI Treatment: Could "The Matrix" Really Be the Future?
    J Am Coll Cardiol. 2016;67:1087-90.
    PubMed     Text format    


  479. WASSENAAR JW, Gaetani R, Garcia JJ, Braden RL, et al
    Evidence for Mechanisms Underlying the Functional Benefits of a Myocardial Matrix Hydrogel for Post-MI Treatment.
    J Am Coll Cardiol. 2016;67:1074-86.
    PubMed     Text format     Abstract available


  480. RADFORD MJ
    Does Public Reporting Improve Care?
    J Am Coll Cardiol. 2016;67:973-5.
    PubMed     Text format    


  481. DEVORE AD, Hammill BG, Hardy NC, Eapen ZJ, et al
    Has Public Reporting of Hospital Readmission Rates Affected Patient Outcomes?: Analysis of Medicare Claims Data.
    J Am Coll Cardiol. 2016;67:963-72.
    PubMed     Text format     Abstract available


  482. BARBANTI M
    TAVR and Left Main Stenting: Can 2 Giants Live in Harmony in a Small Room?
    J Am Coll Cardiol. 2016;67:961-2.
    PubMed     Text format    


  483. CHAKRAVARTY T, Sharma R, Abramowitz Y, Kapadia S, et al
    Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.
    J Am Coll Cardiol. 2016;67:951-60.
    PubMed     Text format     Abstract available


  484. SIBBING D, Gross L, Massberg S
    CYP2C19 in ACS Patients: Could Genotyping Have a Role in Medically Managed Patients or Beyond?
    J Am Coll Cardiol. 2016;67:948-50.
    PubMed     Text format    


  485. DOLL JA, Neely ML, Roe MT, Armstrong PW, et al
    Impact of CYP2C19 Metabolizer Status on Patients With ACS Treated With Prasugrel Versus Clopidogrel.
    J Am Coll Cardiol. 2016;67:936-47.
    PubMed     Text format     Abstract available


  486. CASSESE S, Kastrati A
    Bioresorbable Vascular Scaffold Technology Benefits From Healthy Skepticism.
    J Am Coll Cardiol. 2016;67:932-5.
    PubMed     Text format    


  487. PURICEL S, Cuculi F, Weissner M, Schmermund A, et al
    Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.
    J Am Coll Cardiol. 2016;67:921-31.
    PubMed     Text format     Abstract available


    February 2016
  488. FORDYCE CB, Newby DE, Douglas PS
    Diagnostic Strategies for the Evaluation of Chest Pain: Clinical Implications From SCOT-HEART and PROMISE.
    J Am Coll Cardiol. 2016;67:843-52.
    PubMed     Text format     Abstract available


  489. FUSTER V
    Editor-in-Chief's Top Picks From 2015: Part Two.
    J Am Coll Cardiol. 2016;67:817-42.
    PubMed     Text format     Abstract available


  490. HOLMES DR JR, Mack MJ
    Here Today, Gone Tomorrow.
    J Am Coll Cardiol. 2016;67:777-9.
    PubMed     Text format    


  491. BARTHELEMY O, Montalescot G
    Moving Toward Eradication of Stent Thrombosis.
    J Am Coll Cardiol. 2016;67:763-5.
    PubMed     Text format    


  492. JENSEN LO, Thayssen P, Christiansen EH, Maeng M, et al
    Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV.
    J Am Coll Cardiol. 2016;67:751-62.
    PubMed     Text format     Abstract available


  493. KASTRATI A, Colleran R, Ndrepepa G
    Cardiogenic Shock: How Long Does the Storm Last?
    J Am Coll Cardiol. 2016;67:748-50.
    PubMed     Text format    


  494. SILVAIN J, Kerneis M, Montalescot G
    Potent P2Y12 Inhibitors in Low-Risk Patients: Is There a Medical Need?
    J Am Coll Cardiol. 2016;67:614-7.
    PubMed     Text format    


  495. ANGIOLILLO DJ, Franchi F, Waksman R, Sweeny JM, et al
    Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI.
    J Am Coll Cardiol. 2016;67:603-13.
    PubMed     Text format     Abstract available


  496. HENDERSON RA, Jarvis C, Clayton T, Pocock SJ, et al
    Reply: Survival Differences in Clinical Trials With Long-Term Follow-up.
    J Am Coll Cardiol. 2016;67:601.
    PubMed     Text format    


  497. KOSTIS WJ, Moreyra AE, Cabrera J, Kostis JB, et al
    Survival Differences in Clinical Trials With Long-Term Follow-Up.
    J Am Coll Cardiol. 2016;67:600.
    PubMed     Text format    


  498. NISHIMIYA K, Matsumoto Y, Takahashi J, Uzuka H, et al
    Enhanced Adventitial Vasa Vasorum Formation in Patients With Vasospastic Angina: Assessment With OFDI.
    J Am Coll Cardiol. 2016;67:598-600.
    PubMed     Text format    


  499. JATENE T, Harrington RA, Stone GW, Steg PG, et al
    Investigator-Reported Bleeding Versus Post Hoc Adjudication of Bleeding: Lessons From the CHAMPION PHOENIX Trial.
    J Am Coll Cardiol. 2016;67:596-8.
    PubMed     Text format    


  500. GRADMAN AH
    SPRINT: To Whom Do the Results Apply?
    J Am Coll Cardiol. 2016;67:473-5.
    PubMed     Text format    


  501. BRESS AP, Tanner RM, Hess R, Colantonio LD, et al
    Generalizability of SPRINT Results to the U.S. Adult Population.
    J Am Coll Cardiol. 2016;67:463-72.
    PubMed     Text format     Abstract available


  502. MARIAN AJ
    Genetic Causality in Complex Traits: The Case of Uric Acid.
    J Am Coll Cardiol. 2016;67:417-9.
    PubMed     Text format    


  503. KEENAN T, Zhao W, Rasheed A, Ho WK, et al
    Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
    J Am Coll Cardiol. 2016;67:407-16.
    PubMed     Text format     Abstract available


  504. CHEN-SCARABELLI C, Scarabelli TM
    Cyclosporine A Prior to Primary PCI in STEMI Patients: The Coup de Grace to Post-Conditioning?
    J Am Coll Cardiol. 2016;67:375-8.
    PubMed     Text format    


  505. WRIGHT RS, Murphy J
    PROVE-IT to IMPROVE-IT: Why LDL-C Goals Still Matter in Post-ACS Patients.
    J Am Coll Cardiol. 2016;67:362-4.
    PubMed     Text format    


    January 2016
  506. ALFONSO F, Perez Vizcayno MJ, Cardenas A, Garcia Del Blanco B, et al
    Reply: Drug-Coated Balloon Treatment as Default Strategy for DES-ISR.
    J Am Coll Cardiol. 2016;67:348-9.
    PubMed     Text format    


  507. SCHELLER B, Ong PJ, Kleber F
    Drug-Coated Balloon Treatment as Default Strategy for DES-ISR.
    J Am Coll Cardiol. 2016;67:346-7.
    PubMed     Text format    


  508. HENRIQUES JP, Claessen BE
    A SMILE and a Frown: One-Stage or Multistage PCI in NSTEMI Patients With Multivessel Disease.
    J Am Coll Cardiol. 2016;67:273-4.
    PubMed     Text format    


  509. SARDELLA G, Lucisano L, Garbo R, Pennacchi M, et al
    Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial.
    J Am Coll Cardiol. 2016;67:264-72.
    PubMed     Text format     Abstract available


  510. ABDEL-WAHAB M, Richardt G
    Reply: Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results.
    J Am Coll Cardiol. 2016;67:236-7.
    PubMed     Text format    


  511. MONTONE RA, Testa L, Bedogni F
    Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: CHOICE Trial Results.
    J Am Coll Cardiol. 2016;67:235-6.
    PubMed     Text format    


  512. GIRAL P, Hansel B, Chapman J
    Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.
    J Am Coll Cardiol. 2016;67:234.
    PubMed     Text format    


  513. TSUJITA K, Sugiyama S, Shimomura H, Yamanaga K, et al
    Reply: Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUS.
    J Am Coll Cardiol. 2016;67:234-5.
    PubMed     Text format    


  514. MILLWOOD IY, Bennett DA, Walters RG, Clarke R, et al
    Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults.
    J Am Coll Cardiol. 2016;67:230-1.
    PubMed     Text format    


  515. SCHIEBINGER L, Stefanick ML
    Gender Matters in Biological Research and Medical Practice.
    J Am Coll Cardiol. 2016;67:136-8.
    PubMed     Text format    


  516. TSUJITA K, Sugiyama S, Shimomura H, Yamanaga K, et al
    Reply: Getting What the Guidelines Stated Matters.
    J Am Coll Cardiol. 2016;67:120-1.
    PubMed     Text format    


  517. STONE NJ, Lloyd-Jones D, Smith S
    Getting What the Guidelines Stated Matters.
    J Am Coll Cardiol. 2016;67:119-20.
    PubMed     Text format    


  518. BUDAJ A
    Bleeding and Quality of Life.
    J Am Coll Cardiol. 2016;67:66-8.
    PubMed     Text format    


  519. AMIN AP, Wang TY, McCoy L, Bach RG, et al
    Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.
    J Am Coll Cardiol. 2016;67:59-65.
    PubMed     Text format     Abstract available


  520. BODEN WE, Mancini GB
    CABG for Complex CAD: When Will Evidence-Based Practice Align With Evidence-Based Medicine?
    J Am Coll Cardiol. 2016;67:56-8.
    PubMed     Text format    


  521. MILOJEVIC M, Head SJ, Parasca CA, Serruys PW, et al
    Causes of Death Following PCI Versus CABG in Complex CAD: 5-Year Follow-Up of SYNTAX.
    J Am Coll Cardiol. 2016;67:42-55.
    PubMed     Text format     Abstract available


  522. FARKOUH ME, Douglas PS
    The Management of Acute Chest Pain: What Lies Beyond the Emergency Department Doors?
    J Am Coll Cardiol. 2016;67:27-8.
    PubMed     Text format    


  523. DEDIC A, Lubbers MM, Schaap J, Lammers J, et al
    Coronary CT Angiography for Suspected ACS in the Era of High-Sensitivity Troponins: Randomized Multicenter Study.
    J Am Coll Cardiol. 2016;67:16-26.
    PubMed     Text format     Abstract available


  524. LAVIE CJ, Arena R, Franklin BA
    Cardiac Rehabilitation and Healthy Life-Style Interventions: Rectifying Program Deficiencies to Improve Patient Outcomes.
    J Am Coll Cardiol. 2016;67:13-5.
    PubMed     Text format    


  525. STONE GW, Hochman JS, Williams DO, Boden WE, et al
    Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise.
    J Am Coll Cardiol. 2016;67:81-99.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: